Benign neoplasm of other and unspecified endocrine glands

CD2_BENIGN_ENDOCRINE_OTH

endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D35 Cause of death: ICD-10 — D35 2 out of 7 registries used, show all original rules.	6132
4. Check minimum number of events None	6132
5. Include endpoints CD2_BENIGN_ADRENAL CD2_BENIGN_PARATHYROID CD2_BENIGN_PITUITARY_CRANIPHAR CD2_BENIGN_PINEAL CD2_BENIGN_CAROTIDBODY CD2_BENIGN_AORTICBODY_PARAGANGLIA CD2_BENIGN_PLURIGLANDULAR CD2_BENIGN_ENDOCRINE_NOS	6302
6. Filter based on genotype QC (FinnGen only)	5671

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasmata benigna glandularum endocrinarum aliarum et non specificatarum

NAME	CD2_BENIGN_ENDOCRINE_OTH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_ADRENAL\|CD2_BENIGN_PARATHYROID\|CD2_BENIGN_PITUITARY_CRANIPHAR\|CD2_BENIGN_PINEAL\|CD2_BENIGN_CAROTIDBODY\|CD2_BENIGN_AORTICBODY_PARAGANGLIA\|CD2_BENIGN_PLURIGLANDULAR\|CD2_BENIGN_ENDOCRINE_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D35
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D35
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of other and unspecified endocrine glands based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26190	15605	10411
Only index persons	24177	14637	9540
Unadjusted period prevalence (%)
Whole population	0.38	0.45	0.29
Only index persons	0.47	0.54	0.36
Median age at first event (years)
Whole population	59.28	58.64	60.45
Only index persons	59.12	58.33	60.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5671	3383	2288
Unadjusted period prevalence (%)	1.14	1.20	1.05
Median age at first event (years)	60.39	58.34	63.43

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5887: Matched controls
58870

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

13242.4

307.7

1857

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

1050.9

307.7

655

E23.00

ICD-10 Finland

Panhypopituitarism

155.9

307.7

393

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

69.6

307.7

827

138

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

16384.0

307.7

3155

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

125.1

307.7

263

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

96.9

307.7

925

113

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

667.3

307.7

376

E22.1

ICD-10 Finland

Hyperprolactinaemia

52.1

307.7

475

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

238.0

307.7

294

101

Kela drug reimbursment

Anterior pituitary hypofunction

47.6

307.7

408

ZXC86

NOMESCO Finland

Use of endoscopic device

28.4

307.7

222

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

111.6

307.7

327

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

81.7

307.7

273

H02AB09

ATC

hydrocortisone; systemic

19.3

307.7

875

529

BC1AD

NOMESCO Finland

CT of adrenal glands

74.2

307.7

786

122

N04BC06

ATC

cabergoline; oral

85.0

307.7

419

E26.0

ICD-10 Finland

Primary hyperaldosteronism

31.1

307.7

242

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

2915.7

300.3

288

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

134.2

286.2

144

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

11.3

259.4

277

257

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

97.9

258.1

134

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.8

254.5

488

899

102

Kela drug reimbursment

Diabetes insipidus

61.9

250.7

139

BC4WT

NOMESCO Finland

Selective blood sample from adrenal gland with radiological guidance

106.9

204.0

105

E23.05

ICD-10 Finland

Lack of TSH

27.9

193.6

131

G02CB03

ATC

cabergoline; oral

22.8

183.9

134

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

7.6

179.5

258

351

G02CB01

ATC

bromocriptine; systemic

7.2

164.8

248

355

E21.0

ICD-10 Finland

Primary hyperparathyroidism

6.4

161.9

277

454

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

190.9

160.7

167

E23.2

ICD-10 Finland

Diabetes insipidus

29.9

151.3

100

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.6

145.0

519

1548

BCA30

NOMESCO Finland

Unilateral adrenalectomy

43.2

135.7

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

6.4

135.4

227

364

H53.4

ICD-10 Finland

Visual field defects

5.5

130.4

257

482

H03AA01

ATC

levothyroxine sodium; systemic

2.0

115.3

1643

9476

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

51.3

114.7

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

16.6

113.3

C03DA01

ATC

spironolactone; oral

2.4

112.5

923

4278

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

30.0

112.0

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

8.1

107.8

145

182

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

105.4

1742

10516

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.9

101.7

311

830

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

+∞

101.3

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

100.0

1009

5081

H01AC01

ATC

somatropin; parenteral

23.2

98.1

XCK00

NOMESCO Finland

Perimetry

2.8

95.6

504

1879

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

95.4

1257

6984

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

49.5

93.1

WX402

NOMESCO Finland

General anaesthesia

1.9

92.7

1536

9216

D35.30

ICD-10 Finland

Craniopharyngoma

+∞

89.8

D35.4

ICD-10 Finland

Benign neoplasm: Pineal gland

881.7

88.9

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

88.1

657

2900

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

84.5

3001

22324

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

81.9

1083

5992

D35.59

ICD-10 Finland

Other paragangliom

+∞

79.3

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

6.0

79.1

141

240

E23.03

ICD-10 Finland

Lack of ACTH

17.3

79.0

ZXC95

NOMESCO Finland

Use of surgical navigator

5.4

75.8

150

282

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

74.6

1528

9684

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.3

74.2

296

939

D35.9

ICD-10 Finland

Benign neoplasm: Endocrine gland, unspecified

+∞

72.0

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

128.3

71.0

BBA20

NOMESCO Finland

Exploration of parathyroid gland

12.7

70.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

70.3

2244

15984

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

69.7

3688

29742

H01CB03

ATC

lanreotide; parenteral

13.0

65.7

A10BA02

ATC

metformin; oral

1.7

65.2

1727

11672

E24.8

ICD-10 Finland

Other Cushing syndrome

91.2

65.0

Z3231

NOMESCO Finland

Registered nurse

1.7

64.4

1649

11039

C08CA01

ATC

amlodipine; oral

1.6

63.9

2337

17102

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

26.1

63.4

N02BE01

ATC

paracetamol; systemic, rectal

2.1

63.4

5339

48243

H01CB02

ATC

octreotide; parenteral

12.8

63.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

63.1

668

3387

E260, I152,

ICD-10 Finland

133.5

62.0

G47.3

ICD-10 Finland

Sleep apnoea

1.7

59.2

1455

9601

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

59.0

744

4012

2542

FHL

Transasal hypophysectomy

584.0

58.8

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

6.1

58.1

102

171

AA1AD

NOMESCO Finland

CT of head and brain

1.6

57.4

1749

12173

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

151.5

57.0

A02BC02

ATC

pantoprazole; systemic

1.6

56.7

4099

34685

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

56.4

1765

12353

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

18.1

56.0

BC1BD

NOMESCO Finland

Extensive CT of adrenal glands

102.8

55.9

E66.8

ICD-10 Finland

Other obesity

2.4

55.5

398

1715

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.3

55.5

149

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.8

55.0

126

269

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

53.5

4208

36022

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

53.4

1492

10129

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

53.1

1340

8867

UJF32

NOMESCO Finland

Coloscopy

1.6

52.4

1580

10921

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

52.3

2072

15253

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

52.3

1162

7431

J01DB01

ATC

cefalexin; oral

1.7

50.4

4836

43041

R51.80

ICD-10 Finland

Headache

1.8

50.2

958

5867

301

Kela drug reimbursment

Growth hormone

71.8

50.1

N02AX02

ATC

tramadol; systemic, rectal

1.5

49.3

2515

19479

D35.50

ICD-10 Finland

Carotid body

+∞

49.0

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

47.6

1545

10824

T90

ICPC

Diabetes non-insulin dependent

1.6

47.4

1464

10137

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

46.9

1189

7841

22620

ICD-8 Finland

Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)

+∞

45.9

C07AB07

ATC

bisoprolol; oral

1.5

45.8

2776

22146

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

45.0

1984

14829

E87.6

ICD-10 Finland

Hypokalaemia

2.6

43.0

250

975

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

151.1

42.8

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

42.8

584

3218

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

6.9

42.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

42.7

542

2915

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

42.6

449

2261

E21.2

ICD-10 Finland

Other hyperparathyroidism

7.7

42.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

41.7

778

4713

T73

ICPC

Neoplasm endocrine other/unspecified

15.7

41.7

B01AB05

ATC

enoxaparin; parenteral

1.5

41.6

1823

13556

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

41.5

620

3515

C03CA01

ATC

furosemide; systemic

1.5

40.8

1601

11624

205

Kela drug reimbursment

Chronic hypertension

1.5

40.8

1418

10030

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

8.7

40.5

P01AB01

ATC

metronidazole; oral, rectal

1.5

40.4

2269

17691

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

40.2

2100

16145

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

40.1

616

3521

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

39.8

369

1768

E23.6

ICD-10 Finland

Other disorders of pituitary gland

88.7

39.8

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

+∞

39.6

105

Kela drug reimbursment

Adrenal cortical hypofunction

11.5

39.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

39.1

581

3285

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

39.0

651

3814

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

38.9

387

1905

J01MA02

ATC

ciprofloxacin; systemic

1.5

38.8

2180

16961

N07BA03

ATC

varenicline; oral

2.3

38.6

311

1408

R06.0

ICD-10 Finland

Dyspnoea

1.5

38.5

1563

11405

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

38.3

675

4018

Z71.8

ICD-10 Finland

Other specified counselling

1.5

37.3

1941

14860

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

37.1

586

3374

C02AC05

ATC

moxonidine; oral

2.3

36.9

302

1376

WX882

NOMESCO Finland

High dependency care

2.8

36.5

186

678

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

4.8

36.4

173

R03AC02

ATC

salbutamol; inhalant

1.4

36.2

3083

25749

R03BB04

ATC

tiotropium bromide; inhalant

1.8

35.5

572

3314

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.7

34.5

185

692

WZC30

NOMESCO Finland

Teaching

1.6

34.5

997

6732

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

34.3

1302

9333

H47.2

ICD-10 Finland

Optic atrophy

7.1

34.3

E83.50

ICD-10 Finland

Hypercalcemia

3.6

33.6

112

317

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

33.1

2324

18671

G02CB04

ATC

quinagolide; oral

63.7

33.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

32.9

2456

19928

UKC02

NOMESCO Finland

Cystoscopy

1.6

32.8

873

5776

R53

ICD-10 Finland

Malaise and fatigue

1.5

32.6

1392

10201

22680

ICD-8 Finland

Benign neoplasm of endocrine glands, Other specified endocrine glands

+∞

32.3

M79.6

ICD-10 Finland

Pain in limb

1.4

31.8

2524

20650

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.4

31.7

115

344

JN4AD

NOMESCO Finland

Body CT examination

1.7

31.6

687

4320

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

31.5

1293

9393

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.4

31.2

111

328

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

31.1

379

2005

ZXE00

NOMESCO Finland

One hour or less

1.4

30.7

2079

16538

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.1

30.4

200

D35.6

ICD-10 Finland

Benign neoplasm: Aortic body and other paraganglia

+∞

30.2

2271A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Parathyroid gland

+∞

30.2

CS494

NOMESCO Finland

Other visual field testing

2.6

29.9

175

685

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

29.8

1028

7195

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

29.5

352

1848

J01FF01

ATC

clindamycin; systemic

1.4

29.2

1487

11230

D01

ICPC

Abdominal pain/cramps general

1.6

29.2

696

4476

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

29.2

802

5337

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

29.1

374

2015

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

5.7

29.1

2370A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct

293.4

28.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

28.4

750

4942

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

28.1

362

1951

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

282.9

27.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

27.7

1309

9735

S18

ICPC

Laceration/cut

1.4

27.5

2664

22315

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.7

27.4

243

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

5.9

27.4

R42

ICD-10 Finland

Dizziness and giddiness

1.4

27.4

1265

9369

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

27.3

1668

12978

A10BH01

ATC

sitagliptin; oral

1.7

27.3

534

3260

R4110

NOMESCO Finland

Physiotherapy

1.4

27.2

1533

11762

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

27.2

202

883

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

27.1

596

3753

Z3226

NOMESCO Finland

Physiotherapist

1.5

27.1

975

6874

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

27.0

703

4614

N06AX21

ATC

duloxetine; oral

1.6

27.0

680

4429

H02AB06

ATC

prednisolone; systemic

1.3

26.8

2627

22014

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

26.8

1458

11115

N06AX11

ATC

mirtazapine; oral

1.4

26.7

1864

14818

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

26.6

641

4127

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

26.6

1007

7170

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

26.6

718

4753

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

9.2

26.5

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

26.3

262

1290

N03AX16

ATC

[U] pregabalin

1.4

26.2

1267

9453

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

26.2

537

3320

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

26.2

474

2833

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.8

26.1

131

474

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

36.9

26.1

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

26.0

220

1016

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.4

25.8

172

716

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.3

25.8

159

R02

ICPC

Shortness of breath/dyspnoea

1.6

25.5

754

5091

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

25.4

633

4109

A28

ICPC

Limited function/disability NOS

1.5

25.2

936

6631

A02BC05

ATC

esomeprazole; systemic

1.3

25.1

2239

18442

A10BJ06

ATC

semaglutide; parenteral

1.9

24.8

322

1740

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

24.5

739

5010

N06AB10

ATC

escitalopram; oral

1.5

24.5

1050

7648

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

24.5

2410

20119

C08CA13

ATC

lercanidipine; oral

1.5

24.4

804

5554

Y28

ICPC

Limited function/disability (Y)

5.8

24.4

T99

ICPC

Endocr/metab/nutrit disease other

3.0

24.4

111

381

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

24.4

447

2679

C09CA01

ATC

losartan; oral

1.4

24.4

1418

10905

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.7

24.1

126

466

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

24.1

576

3700

2270A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Adrenal gland

+∞

24.0

C10AA05

ATC

atorvastatin; oral

1.3

23.9

2328

19381

R31

ICD-10 Finland

Unspecified haematuria

1.6

23.8

535

3385

N06AX16

ATC

venlafaxine; oral

1.5

23.7

760

5217

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

23.6

894

6351

L28

ICPC

Limited function/disability (L)

1.4

23.5

1030

7526

H02AA02

ATC

fludrocortisone; oral

4.2

23.2

146

N28.1

ICD-10 Finland

Cyst of kidney

3.0

23.2

101

338

A11CC03

ATC

alfacalcidol; systemic

2.5

23.2

145

587

C10AA01

ATC

simvastatin; oral

1.3

23.2

2148

17734

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

28.3

23.1

SPAT1262

SPAT

Handing over of treatment supplies

1.5

23.1

913

6541

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

22.9

971

7050

N03AX12

ATC

[U] gabapentin; oral

1.5

22.6

880

6281

H05BX01

ATC

cinacalcet; oral

4.4

22.6

128

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

22.4

594

3906

S10

ICPC

Boil/carbuncle

1.8

22.4

339

1921

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

22.4

1300

9971

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

22.4

2828

24341

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

22.4

648

4348

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

4.4

22.4

125

SPAT1254

SPAT

Administration of medicine

1.5

22.3

732

5046

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

22.3

723

4971

G44.2

ICD-10 Finland

Tension-type headache

1.5

22.2

731

5043

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

22.0

254

1318

ZX120

NOMESCO Finland

Intravenous

1.6

21.8

499

3168

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

21.6

939

6841

N06AB04

ATC

citalopram; systemic

1.4

21.6

1084

8108

A10BK01

ATC

dapagliflozin; oral

1.7

21.5

447

2768

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

21.5

1025

7593

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

21.4

431

2648

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

21.4

416

2532

E23.0

ICD-10 Finland

Hypopituitarism

43.5

21.4

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

21.3

239

1228

J01MA12

ATC

levofloxacin; systemic

1.4

21.2

960

7045

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

21.2

305

1703

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.0

21.0

216

1077

ZXA10

NOMESCO Finland

Bilateral

1.4

20.9

945

6929

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

28.1

20.9

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

28.1

20.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

20.9

1462

11535

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

20.9

585

3894

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

20.9

2017

16683

BDA10

NOMESCO Finland

Operation on carotid body

+∞

20.8

D352, E221,

ICD-10 Finland

+∞

20.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

20.6

247

1299

25320

ICD-8 Finland

Diseases of pituitary gland, Chromophobe adenoma, pituitary

110.4

20.6

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

110.4

20.6

R10.0

ICD-10 Finland

Acute abdomen

2.1

20.5

190

910

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

6.5

20.4

R60.0

ICD-10 Finland

Localized oedema

1.5

20.4

691

4790

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

41.8

20.4

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

25.6

20.4

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

20.3

1405

11059

N05CF01

ATC

zopiclone; oral

1.3

20.3

1667

13463

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

20.2

833

6004

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

20.1

315

1803

A10BK03

ATC

empagliflozin; oral

1.6

20.1

565

3762

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

20.0

132

A46

ICD-10 Finland

Erysipelas

1.5

20.0

775

5518

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

20.0

120

477

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

20.0

575

3851

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

6.8

19.9

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

19.9

2997

26234

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

19.9

149

655

C09CA03

ATC

valsartan; oral

1.6

19.8

503

3273

2530A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]

+∞

19.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

19.5

918

6776

K86.2

ICD-10 Finland

Cyst of pancreas

3.0

19.2

272

M54.5

ICD-10 Finland

Low back pain

1.3

19.1

1968

16371

R11

ICD-10 Finland

Nausea and vomiting

1.6

19.1

454

2908

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

19.0

1160

8940

Z2221

NOMESCO Finland

Medical doctor

1.3

18.9

1379

10921

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

18.9

534

3561

TAB00

NOMESCO Finland

Lumbar puncture

1.9

18.7

236

1263

A10BJ02

ATC

liraglutide; parenteral

2.2

18.7

166

783

E23.08

ICD-10 Finland

Hypopituitarism

27.9

18.7

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

18.7

762

5476

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

18.6

813

5918

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

18.6

593

4058

N05BA04

ATC

oxazepam; oral

1.3

18.5

1351

10697

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

18.5

522

3478

N05AH04

ATC

quetiapine; oral

1.4

18.5

876

6469

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

18.4

1887

15665

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

18.3

1520

12260

A04

ICPC

Weakness/tiredness general

1.4

18.2

805

5868

E23.7

ICD-10 Finland

Disorder of pituitary gland, unspecified

44.1

18.2

V04CD01

ATC

metyrapone; oral

44.1

18.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

18.2

406

2560

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

18.2

594

4085

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

18.1

192

968

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

18.0

1620

13208

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

4.8

18.0

J01AA02

ATC

doxycycline; systemic

1.3

17.9

4320

39891

106

Kela drug reimbursment

Hypoparathyroidism

5.1

17.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

17.8

1317

10437

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.7

17.7

340

AA4DM

NOMESCO Finland

Very extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

17.7

E27.2

ICD-10 Finland

Addisonian crisis

20.1

17.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

17.6

1510

12220

WX892

NOMESCO Finland

Monitored bed care

1.6

17.6

383

2399

A08

ICPC

Swelling

1.7

17.6

316

1883

JAH01

NOMESCO Finland

Laparoscopy

1.9

17.5

237

1298

N20.0

ICD-10 Finland

Calculus of kidney

2.4

17.4

122

521

D06

ICPC

Abdominal pain localized other

1.6

17.4

480

3182

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.0

17.4

256

L17

ICPC

Foot/toe symptom/complaint

1.3

17.4

1659

13621

A10BH05

ATC

linagliptin; oral

1.8

17.4

266

1514

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

17.4

399

2534

ZXD05

NOMESCO Finland

Urgent procedure

1.3

17.3

1481

11982

WX704

NOMESCO Finland

Intubation

1.6

17.2

431

2796

C08CA02

ATC

felodipine; oral

1.6

17.1

466

3081

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

17.0

708

5101

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.2

17.0

140

641

C10AA07

ATC

rosuvastatin; oral

1.3

16.9

1851

15459

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

16.9

434

2830

SPAT1263

SPAT

Sampling

1.3

16.8

2126

18073

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

16.8

471

3134

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

16.7

202

1067

JN4BD

NOMESCO Finland

Extensive body CT

1.5

16.7

524

3571

M48.0

ICD-10 Finland

Spinal stenosis

1.5

16.6

637

4518

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

6.5

16.6

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.5

16.6

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

16.6

2436

21082

A02BA02

ATC

ranitidine; systemic

1.4

16.5

945

7191

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

16.5

256

1464

A12BA01

ATC

potassium chloride; oral

1.9

16.4

191

997

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

16.3

342

2123

WF002

NOMESCO Finland

Radical radiotherapy

1.7

16.3

292

1739

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

16.2

691

4999

C09AA02

ATC

enalapril; systemic

1.4

16.2

924

7027

M03BX02

ATC

tizanidine; oral

1.3

16.1

3360

30242

WX290

NOMESCO Finland

Other blockage of nerve

1.3

16.1

2447

21236

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

16.0

377

2407

A01

ICPC

Pain general/multiple sites

1.5

16.0

542

3750

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

16.0

329

2031

A02BC03

ATC

lansoprazole; oral

1.3

16.0

1446

11760

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

47.6

16.0

2533

FHL

Unilateral removal of additional egg

47.6

16.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

16.0

526

3619

A02BC01

ATC

omeprazole; systemic

1.3

16.0

1373

11092

N06AA09

ATC

amitriptyline; systemic

1.5

15.8

484

3283

XG466

NOMESCO Finland

Sleep oxymetry

2.0

15.7

163

816

N17

ICPC

Vertigo/dizziness

1.4

15.7

666

4813

D35.3

ICD-10 Finland

Benign neoplasm: Craniopharyngeal duct

+∞

15.6

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

15.5

214

1181

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.4

15.4

164

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

15.4

347

2194

N20.1

ICD-10 Finland

Calculus of ureter

1.9

15.4

191

1019

WVA30, ,

SPAT

1.6

15.3

356

2266

A06AD11

ATC

lactulose; oral

1.4

15.2

692

5064

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

17.8

15.1

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

15.1

335

2109

A10AE04

ATC

insulin glargine; parenteral

1.5

15.0

470

3200

B01AB04

ATC

dalteparin; parenteral

1.7

15.0

260

1534

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

14.9

1279

10314

Z72.0

ICD-10 Finland

Tobacco use

2.1

14.9

141

683

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

14.9

497

3429

K02.1

ICD-10 Finland

Caries of dentine

1.2

14.9

3123

28011

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

14.9

216

1211

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

14.9

189

1016

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

14.9

611

4389

Z01.7

ICD-10 Finland

Laboratory examination

1.4

14.8

868

6625

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

14.8

229

1309

M01AB05

ATC

diclofenac; systemic, rectal

1.2

14.7

3573

32546

N02AA05

ATC

oxycodone; systemic

1.4

14.7

911

7011

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

5.3

14.6

J01DA01

ATC

[U] cefalexin

1.2

14.6

3232

29127

EBA00

NOMESCO Finland

Extraction of tooth

1.3

14.6

1857

15731

D35.7

ICD-10 Finland

Benign neoplasm: Other specified endocrine glands

+∞

14.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

14.6

409

2720

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

14.6

314

1963

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

14.5

717

5319

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

14.5

300

1856

N06AX12

ATC

bupropion; oral

1.6

14.5

334

2123

D11

ICPC

Diarrhoea

1.4

14.5

585

4188

H47.4

ICD-10 Finland

Disorders of optic chiasm

150.4

14.5

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

14.5

3570

32549

XX9XW, ,

NOMESCO Finland

3.7

14.4

123

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

14.4

306

1907

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

12.5

14.3

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

14.3

115

522

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.4

14.3

397

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

14.3

104

453

C07AA05

ATC

propranolol; systemic

1.3

14.3

981

7665

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

14.2

1466

12098

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.3

14.2

102

442

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

14.2

2526

22210

M25.5

ICD-10 Finland

Pain in joint

1.3

14.2

1760

14858

J01CA04

ATC

amoxicillin; systemic

1.3

14.1

4473

41907

S06.0

ICD-10 Finland

Concussion

1.5

14.1

518

3643

XKD00

NOMESCO Finland

Uroflowmetry

1.4

14.0

729

5454

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

3.9

13.9

103

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

13.9

270

1645

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

13.8

941

7342

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.8

13.7

208

1181

M01AE02

ATC

naproxen; oral, rectal

1.2

13.7

2957

26499

C09DA01

ATC

losartan and diuretics; oral

1.4

13.7

550

3932

C09CA06

ATC

candesartan; oral

1.3

13.7

1257

10216

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

13.7

208

1183

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

3.9

13.7

100

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

6.5

13.6

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

13.6

643

4731

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

13.6

974

7653

E27.0

ICD-10 Finland

Other adrenocortical overactivity

14.7

13.5

B01AB10

ATC

tinzaparin; parenteral

1.4

13.5

572

4130

2532A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]

140.3

13.4

C03AA03

ATC

hydrochlorothiazide; oral

1.5

13.4

430

2941

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.2

13.4

112

517

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

13.4

289

1807

A55

ICPC

General and Unspecified, Local injection/infiltration

2.6

13.4

278

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

13.3

249

1501

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.2

13.3

105

474

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

13.3

361

2385

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

13.3

795

6081

Z2446

NOMESCO Finland

Social worker

1.6

13.2

298

1885

R4110, ,

SPAT

1.4

13.2

718

5408

R07.3

ICD-10 Finland

Other chest pain

1.4

13.2

526

3755

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

13.2

798

6112

J01FA10

ATC

azithromycin; systemic

1.2

13.2

2971

26702

UDM02

NOMESCO Finland

Sinoscopy

2.1

13.1

120

575

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

4.3

13.1

N01

ICPC

Headache

1.4

13.1

516

3676

B01AF02

ATC

apixaban; oral

1.4

13.1

662

4928

K30

ICD-10 Finland

Functional dyspepsia

1.4

13.1

583

4247

WX002

NOMESCO Finland

Sedation and analgesia

1.3

13.0

953

7508

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

13.0

219

1284

R35

ICD-10 Finland

Polyuria

1.5

12.9

346

2280

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

12.8

198

1132

T82

ICPC

Obesity

1.8

12.8

207

1199

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

12.8

620

4582

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

12.8

599

4402

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

12.7

264

1636

R4120

NOMESCO Finland

Occupational therapy

1.6

12.7

328

2142

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

12.7

236

1421

N02BF01

ATC

gabapentin; oral

1.4

12.7

548

3969

-50

ICPC

Medication/prescr/renewal

1.8

12.6

193

1100

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.0

12.6

139

714

R5110, ,

SPAT

1.5

12.5

446

3115

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

12.5

949

7505

R4190

NOMESCO Finland

Nutritional therapy

1.8

12.5

195

1117

D35.8

ICD-10 Finland

Benign neoplasm: Pluriglandular involvement

+∞

12.5

R04.2

ICD-10 Finland

Haemoptysis

1.9

12.5

166

907

N30.0

ICD-10 Finland

Acute cystitis

1.3

12.4

856

6679

AA4AD

NOMESCO Finland

CT of sella turcica

130.3

12.4

N04BC01

ATC

bromocriptine; oral

20.1

12.4

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.2

12.4

A98

ICPC

Health maint/preventive medicine

1.6

12.4

5627

54806

E66

ICD-10 Finland

Obesity

1.6

12.3

271

1705

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

3.4

12.3

132

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.4

12.3

351

C07AB02

ATC

metoprolol; systemic

1.3

12.2

907

7150

ZXA05

NOMESCO Finland

Left side

1.3

12.2

1178

9614

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

12.2

343

2283

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

12.2

152

814

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

12.2

3875

35933

SPAT1153

SPAT

Removal of sutures

1.2

12.1

1587

13432

R55

ICD-10 Finland

Syncope and collapse

1.4

12.0

521

3774

SPAT1240

SPAT

Therapeutic discussion

1.4

12.0

455

3216

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

18.1

12.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

12.0

1117

9073

K07

ICPC

Swollen ankles/oedema

1.7

12.0

234

1428

OAB50, ,

SPAT

1.5

11.9

419

2919

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

11.9

309

2022

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.7

11.8

243

ZXA00

NOMESCO Finland

Right side

1.3

11.8

1275

10546

N75

ICPC

Benign neoplasm nervous system

11.7

11.8

R06AE07

ATC

cetirizine; oral

1.2

11.8

2250

19805

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

11.7

193

1124

R51

ICD-10 Finland

Headache

1.6

11.7

262

1654

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

11.7

394

2722

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

11.7

291

1884

Z00.8

ICD-10 Finland

Other general examinations

1.5

11.7

380

2608

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.7

2073

18106

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

11.6

415

2900

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

11.6

191

1112

Z00.0

ICD-10 Finland

General medical examination

1.3

11.6

943

7524

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.8

11.6

172

972

I152, E260,

ICD-10 Finland

65.1

11.6

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.0

11.6

126

644

JEA01

NOMESCO Finland

Laparoscopic appendectomy

1.8

11.6

176

1002

N03AX11

ATC

topiramate; oral

2.0

11.6

117

583

DCB00

NOMESCO Finland

Excision of lesion of middle ear

22.9

11.6

A03

ICPC

Fever

1.3

11.5

805

6289

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

2.7

11.5

235

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.2

11.5

431

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

11.5

614

4608

AA4BD

NOMESCO Finland

Extensive CT of sella turcica

+∞

11.5

AA4BM

NOMESCO Finland

MRI examination of sella turcica with 3 Tesla magnet

+∞

11.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

11.5

534

3918

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

11.4

1338

11174

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.2

11.3

139

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.3

1047

8494

R52.9

ICD-10 Finland

Pain, unspecified

1.4

11.3

519

3798

P03

ICPC

Feeling depressed

1.4

11.3

438

3110

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

11.3

187

1092

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.5

11.3

105

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

11.3

351

2388

RD211, ,

NOMESCO Finland

1.7

11.3

212

1282

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.2

11.2

416

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.2

11.2

391

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.2

1147

9422

SPAT1301

SPAT

No procedures

1.2

11.2

1504

12746

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

11.2

285

1857

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.9

11.2

145

787

M01AH05

ATC

etoricoxib; oral

1.2

11.1

3366

30903

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

25.0

11.1

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.3

11.1

367

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

11.0

163

921

-1, ,

NOMESCO Finland

1.2

11.0

1584

13516

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

11.0

712

5501

Z31.5

ICD-10 Finland

Genetic counselling

1.6

11.0

250

1586

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

9.2

11.0

207

Kela drug reimbursment

Chronic arrhythmias

1.3

11.0

732

5682

J01DA09

ATC

[U] cefadroxil

1.3

11.0

1272

10600

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.9

1211

10037

L03

ICPC

Low back symptom/complaint

1.2

10.9

1502

12755

N03AX09

ATC

lamotrigine; oral

1.7

10.9

216

1324

L13

ICPC

Hip symptom/complaint

1.3

10.9

1003

8130

M01AH01

ATC

celecoxib; oral

1.3

10.9

876

6978

C09DA03

ATC

valsartan and diuretics; oral

1.6

10.9

233

1457

N02BF02

ATC

pregabalin; oral

1.5

10.8

346

2366

N06AB03

ATC

fluoxetine; oral

1.4

10.8

575

4312

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

10.8

436

3120

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

10.6

10.7

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

10.7

1350

11350

C08CA05

ATC

nifedipine; systemic

1.6

10.7

260

1675

E83.51

ICD-10 Finland

Hypocalcemia

3.1

10.7

139

C10AC01

ATC

colestyramine; oral

1.9

10.6

137

742

D44.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Parathyroid gland

12.9

10.6

E89.39

ICD-10 Finland

Postprocedural hypopituitarism, other or several procedures

60.1

10.6

R01AD09

ATC

mometasone; nasal

1.2

10.6

2314

20569

L14

ICPC

Leg/thigh symptom/complaint

1.4

10.6

403

2852

J01FA06

ATC

roxithromycin; oral

1.2

10.6

1984

17379

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.9

10.5

C09BA02

ATC

enalapril and diuretics; systemic

1.5

10.4

361

2509

H01AX01

ATC

pegvisomant; parenteral

+∞

10.4

M14.5*E22.0

ICD-10 Finland

Arthropathy associated with acromegaly

+∞

10.4

E22

ICD-10 Finland

Hyperfunction of pituitary gland

+∞

10.4

P06

ICPC

Sleep disturbance

1.3

10.4

621

4739

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

10.4

438

3157

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

10.4

214

1325

S29

ICPC

Skin symptom/complaint other

1.3

10.4

1038

8492

J20

ICD-10 Finland

Acute bronchitis

1.4

10.4

502

3706

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

1.9

10.4

125

663

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.3

719

5611

H02AB07

ATC

prednisone; oral

1.3

10.3

636

4876

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

4.2

10.3

2159

FHL

Other measure in this category

16.0

10.3

B01AA03

ATC

warfarin; systemic

1.3

10.3

805

6381

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.0

10.3

114

587

160

Kela drug reimbursment

exenatide

2.1

10.3

485

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

10.3

705

5492

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.5

10.2

314

2130

RD210, ,

NOMESCO Finland

2.2

10.2

387

G04CA02

ATC

tamsulosin; oral

1.3

10.2

1022

8362

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

10.2

204

1255

C08CA10

ATC

nilvadipine; oral

2.1

10.2

447

R95

ICPC

Chron obstructive pulmonary disease

1.8

10.1

146

819

R03BA05

ATC

fluticasone; inhalant

1.3

10.1

849

6793

E29.1

ICD-10 Finland

Testicular hypofunction

2.4

10.1

269

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

10.1

477

3506

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

10.1

143

798

A12AA04

ATC

calcium carbonate; oral

2.3

10.1

344

G93.0

ICD-10 Finland

Cerebral cysts

3.9

10.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

10.1

922

7459

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

10.1

422

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.8

10.1

148

836

PD5AD

NOMESCO Finland

CT of aorta

1.9

10.0

122

649

R04

ICPC

Breathing problem other

1.7

10.0

193

1176

L86

ICPC

Back syndrome with radiating pain

1.5

10.0

309

2100

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.0

9.9

108

553

ZX114

NOMESCO Finland

Intramuscular

2.4

9.9

290

A10BJ05

ATC

dulaglutide; parenteral

2.0

9.9

104

526

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

9.9

686

5349

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

9.9

638

4927

J02AC01

ATC

fluconazole; systemic

1.2

9.9

1960

17236

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

9.8

137

761

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

12.2

9.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

9.8

248

1615

K92.1

ICD-10 Finland

Melaena

1.6

9.8

237

1528

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.4

9.7

262

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

2.6

9.7

203

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

9.7

355

2494

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.8

9.7

129

707

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

9.7

121

650

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.7

1370

11647

OAB42

NOMESCO Finland

Guidance related to known health problem

3.8

9.7

BBA50

NOMESCO Finland

Total parathyroidectomy

13.4

9.7

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

2.9

9.6

148

C09DA06

ATC

candesartan and diuretics; oral

1.4

9.6

362

2558

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.6

9.6

200

1243

104

Kela drug reimbursment

Thyroid insufficiency

1.5

9.6

335

2334

Z2445

NOMESCO Finland

Psychologist

1.7

9.5

164

969

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

9.5

694

5450

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

9.5

234

1514

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

9.5

1254

10580

B01AC04

ATC

clopidogrel; oral

1.3

9.5

755

6000

XF402

NOMESCO Finland

ECG with work load test

1.4

9.5

491

3667

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

9.4

212

1342

8680/3-C75.5

ICD-O-3

Paraganglioma, NOS, of aortic body and other paraganglia

100.2

9.4

C07AG02

ATC

carvedilol; oral

1.5

9.4

259

1718

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.7

9.4

151

876

9350/1-C75.1

ICD-O-3

Craniopharyngioma, NOS, of pituitary gland

+∞

9.4

D352, E220,

ICD-10 Finland

+∞

9.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.7

9.4

155

907

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.3

2194

19565

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

21.7

9.3

H53.2

ICD-10 Finland

Diplopia

1.7

9.3

158

930

WVA20, ,

SPAT

1.7

9.3

177

1076

J01FA09

ATC

clarithromycin; systemic

1.2

9.3

1531

13209

S04

ICPC

Lump/swelling localized

1.4

9.3

532

4035

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

9.2

332

2325

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.3

9.2

281

E0000UV, ,

ATC

1.2

9.2

2103

18698

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

9.2

499

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

9.2

265

1776

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

2.3

9.2

288

3051, ,

Kela drug reimbursment

2.4

9.2

239

N06AB06

ATC

sertraline; oral

1.4

9.2

519

3929

R01AD08

ATC

fluticasone; nasal

1.2

9.2

1388

11872

I11

ICD-10 Finland

Hypertensive heart disease

3.3

9.1

100

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

9.1

495

3722

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

9.1

126

699

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

9.1

128

714

T28

ICPC

Limited function/disability (T)

2.5

9.1

210

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

9.1

325

2274

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

9.1

282

1919

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

11.5

9.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

9.0

1061

8832

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

9.0

1384

11848

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

3.4

9.0

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

2.6

9.0

205

N05BA01

ATC

diazepam; systemic, rectal

1.3

9.0

591

4573

N06AX22

ATC

agomelatine; oral

1.9

9.0

106

559

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

9.0

435

3212

K04.0

ICD-10 Finland

Pulpitis

1.4

9.0

401

2922

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

9.0

395

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

9.0

307

2131

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

9.0

196

1234

R04.0

ICD-10 Finland

Epistaxis

1.4

8.9

348

2474

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

8.9

2204

19722

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.9

434

3209

BAA60

NOMESCO Finland

Total thyroidectomy

1.8

8.9

118

647

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

8.9

259

1741

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

4.3

8.9

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

8.8

436

3229

G03DB01

ATC

dydrogesterone; oral

1.3

8.8

552

4240

U04

ICPC

Incontinence urine

1.5

8.8

274

1865

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

8.8

498

3768

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.8

621

4852

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

8.8

133

759

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

8.8

416

3061

A10BX07

ATC

[U] liraglutide

2.3

8.8

275

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

10.7

8.8

I50.0

ICD-10 Finland

Congestive heart failure

1.5

8.8

289

1991

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

8.8

1108

9296

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

8.7

695

5520

L20

ICPC

Joint symptom/complaint NOS

1.6

8.7

180

1117

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.3

8.7

295

WVA20

NOMESCO Finland

Medicine administration

1.8

8.7

132

754

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

14.0

8.7

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

8.7

463

3473

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

8.6

495

3756

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.4

8.6

228

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.4

8.6

222

S97

ICPC

Chronic ulcer skin

1.5

8.6

288

1991

M04AA01

ATC

allopurinol; systemic

1.3

8.6

575

4461

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

8.6

247

1656

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.5

3501

32630

162

Kela drug reimbursment

liraglutide

2.4

8.5

241

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

8.5

305

2135

R83

ICPC

Respiratory infection other

1.2

8.5

1168

9878

R01AD58

ATC

fluticasone, combinations; nasal

1.2

8.5

1188

10065

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

8.5

252

1700

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

8.5

606

4745

N05CF02

ATC

zolpidem; oral

1.3

8.4

822

6695

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

90.2

8.4

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

3.9

8.4

S21

ICPC

Skin texture symptom/complaint

1.3

8.4

749

6035

C09DA07

ATC

telmisartan and diuretics; oral

1.6

8.4

194

1239

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

12.8

8.4

T92

ICPC

Gout

1.9

8.3

524

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.6

8.3

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

8.3

173

1076

2550C

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]

+∞

8.3

2549, ,

FHL

+∞

8.3

D350, E260,

ICD-10 Finland

+∞

8.3

E2300, D352,

ICD-10 Finland

+∞

8.3

D44.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct

+∞

8.3

AN1

Coronary angiography

1.3

8.3

469

3548

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.6

8.3

166

1023

XW000

NOMESCO Finland

Bone marrow biopsy

1.6

8.3

187

1187

ZZC00

NOMESCO Finland

Graft of fascia

8.5

8.3

C08DB01

ATC

diltiazem; oral

1.6

8.3

203

1314

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

8.3

592

4635

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

8.3

153

924

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

8.3

271

1866

K08.3

ICD-10 Finland

Retained dental root

1.4

8.3

369

2689

R06.5

ICD-10 Finland

Mouth breathing

1.4

8.2

414

3076

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

3.1

8.2

107

SPAT1252

SPAT

Overall medication plan or its review

1.5

8.2

288

2009

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.3

8.2

277

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

8.2

394

2906

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.2

3042

28079

R52.2

ICD-10 Finland

Other chronic pain

1.6

8.2

181

1143

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

8.2

513

J01CA08

ATC

pivmecillinam; oral

1.2

8.2

1964

17492

C07BB07

ATC

bisoprolol and thiazides; systemic

1.6

8.2

176

1104

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.8

8.2

110

606

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

8.2

235

1575

N03AX14

ATC

levetiracetam; systemic

1.7

8.2

132

768

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

2.8

8.1

140

D02

ICPC

Abdominal pain epigastric

1.4

8.1

298

2096

XCH00

NOMESCO Finland

Eye pressure measurement

1.5

8.1

225

1496

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

8.1

661

5263

D12

ICPC

Constipation

1.6

8.1

173

1083

X14

ICPC

Vaginal discharge

2.0

8.1

431

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.4

8.1

216

A97

ICPC

No disease

1.2

8.1

969

8074

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

8.1

134

785

ZY010

NOMESCO Finland

Hospital outpatient

1.5

8.1

223

1481

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

2.8

8.1

146

A10BB12

ATC

glimepiride; oral

1.5

8.1

263

1808

G04BD08

ATC

solifenacin; oral

1.4

8.1

299

2107

E24

ICD-10 Finland

Cushing syndrome

33.4

8.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.1

8.1

351

ZYC03

NOMESCO Finland

Remote contact, text-based

3.0

8.1

119

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

8.0

901

7454

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

1.8

8.0

107

588

C09AA05

ATC

ramipril; oral

1.2

8.0

1148

9746

J01MA06

ATC

norfloxacin; oral

1.3

8.0

584

4584

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.6

8.0

U05

ICPC

Urination problems other

1.5

8.0

250

1706

M01AH03

ATC

valdecoxib; oral

1.5

8.0

282

1971

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

8.0

517

3993

R05

ICPC

Cough

1.2

7.9

1234

10561

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

7.9

185

1184

R03BA02

ATC

budesonide; inhalant

1.3

7.9

833

6841

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

4.3

7.9

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

7.9

174

1098

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

7.9

362

2649

M54.3

ICD-10 Finland

Sciatica

1.4

7.9

284

1991

JF2BD

NOMESCO Finland

Extensive colon CT

2.6

7.9

171

G04BD12

ATC

mirabegron; oral

1.3

7.9

582

4575

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.7

7.9

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

7.9

447

3386

A10AB05

ATC

insulin aspart; parenteral

1.4

7.9

338

2448

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.8

504

3888

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

6.1

7.8

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

7.8

140

839

A05

ICPC

Feeling ill

1.5

7.8

241

1641

SPAT1059

SPAT

Spirometry at the office

1.5

7.8

228

1535

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.2

7.8

290

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

7.8

473

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.2

7.8

284

B02AA02

ATC

tranexamic acid; systemic

1.3

7.7

667

5350

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.8

7.7

117

669

K57

ICD-10 Finland

Diverticular disease of intestine

1.8

7.7

107

596

BCA41

NOMESCO Finland

Endoscopic bilateral adrenalectomy

45.0

7.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.7

1199

10262

D09

ICPC

Nausea

1.6

7.7

193

1257

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

2.7

7.7

139

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

7.7

1016

8554

358

Kela drug reimbursment

liraglutide

3.1

7.7

R74

ICPC

Upper respiratory infection acute

1.2

7.7

1533

13426

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

2.7

7.6

145

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

7.6

427

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.8

7.6

107

598

SPAT1260

SPAT

Consultation of another employee

1.3

7.6

799

6559

SPAT1216

SPAT

Assessment of functional ability

1.3

7.6

679

5468

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

7.6

238

1624

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.0

7.6

400

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

7.6

144

876

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

7.6

1106

9401

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

7.6

272

1906

E66.0

ICD-10 Finland

Obesity due to excess calories

2.3

7.6

223

J96.1

ICD-10 Finland

Chronic respiratory failure

1.9

7.6

470

H01

ICPC

Ear pain/earache

1.3

7.6

534

4172

K85

ICPC

Elevated blood pressure

1.2

7.6

821

6767

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

1.8

7.5

109

615

A10BD07

ATC

metformin and sitagliptin; systemic

1.6

7.5

190

1239

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

7.5

177

1136

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.5

2831

26090

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

7.5

111

631

J45

ICD-10 Finland

Asthma

1.3

7.5

482

3719

PA2AD

NOMESCO Finland

CT angiography of brain

2.4

7.5

206

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

7.5

192

1258

M02AA07

ATC

piroxicam; topical

1.2

7.4

1729

15331

C02CA01

ATC

prazosin; oral

2.2

7.4

289

WX722

NOMESCO Finland

PEEP

1.5

7.4

201

1331

D07AC01

ATC

betamethasone; topical

1.2

7.4

1810

16112

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

7.4

116

670

JLC00

NOMESCO Finland

Excision of lesion of pancreas

80.2

7.4

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

7.4

531

PD7ZT

NOMESCO Finland

Stent grafting of abdominal aorta

3.5

7.4

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.5

7.4

171

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.4

1495

13099

R4140

NOMESCO Finland

Psychotherapy

3.1

7.4

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

7.4

183

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

7.4

1167

9998

M01AB55

ATC

diclofenac, combinations; oral

1.4

7.4

292

2085

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

7.4

184

1198

J01DC02

ATC

cefuroxime; systemic

1.5

7.3

241

1663

A29

ICPC

General symptom/complaint other

1.3

7.3

639

5134

E24.1

ICD-10 Finland

Nelson syndrome

+∞

7.3

8272/3-C75.1

ICD-O-3

Pituitary carcinoma, NOS, of pituitary gland

+∞

7.3

23990

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Glandulae pituitariae et ductus craniopharyngice

+∞

7.3

D35

ICD-10 Finland

Benign neoplasm of other and unspecified endocrine glands

+∞

7.3

J01CF05

ATC

flucloxacillin; systemic

1.4

7.3

324

2361

SPAT1058

SPAT

PEF monitoring instruction

1.4

7.3

360

2670

J01DA06

ATC

[U] cefuroxime

1.3

7.3

646

5200

N03AX18

ATC

lacosamide; systemic

2.6

7.3

149

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

4.1

7.3

L15

ICPC

Knee symptom/complaint

1.2

7.3

1263

10916

WF099

NOMESCO Finland

Other radiotherapy

2.8

7.2

121

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

7.2

540

4252

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

7.2

238

1642

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

15.7

7.2

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

7.2

211

1422

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

7.2

566

4488

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

7.2

206

1382

C09AA04

ATC

perindopril; oral

1.5

7.2

211

1423

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

3.0

7.2

100

K63.5

ICD-10 Finland

Polyp of colon

1.7

7.2

112

647

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

7.1

332

2438

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.6

7.1

176

1143

E26

ICD-10 Finland

Hyperaldosteronism

20.0

7.1

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

2.3

7.1

236

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.1

7.1

321

N19

ICD-10 Finland

Unspecified kidney failure

1.6

7.1

154

970

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.1

7.1

308

K04.08

ICD-10 Finland

Other specified pulpit

1.4

7.1

336

2475

S76

ICPC

Skin infection other

1.4

7.1

251

1757

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.4

7.1

262

1849

OAB72

NOMESCO Finland

Weight control and weight loss guidance

2.4

7.1

181

R33

ICD-10 Finland

Retention of urine

1.4

7.0

329

2418

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.6

7.0

139

856

N06AX26

ATC

vortioxetine; oral

1.4

7.0

322

2360

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

2.7

7.0

129

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.0

4991

48266

H54.7

ICD-10 Finland

Unspecified visual loss

2.6

7.0

152

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.0

690

5623

U07

ICPC

Urine symptom/complaint other

1.3

7.0

401

3043

WX723

NOMESCO Finland

CPAP therapy

1.5

7.0

202

1358

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

7.0

588

4702

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

7.0

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

3.4

7.0

K96

ICPC

Haemorrhoids

1.7

6.9

129

782

C09CA07

ATC

telmisartan; oral

1.4

6.9

342

2537

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

6.9

279

2000

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

6.9

490

3832

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.9

1899

17048

PC5CG

NOMESCO Finland

Extensive MRI examination of kidney vasculature with high intensity magnet

5.4

6.9

R03DC03

ATC

montelukast; oral

1.2

6.9

772

6382

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.7

6.9

120

715

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

1.9

6.9

429

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

6.9

334

2470

J01EA01

ATC

trimethoprim; systemic

1.2

6.9

1193

10302

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.0

6.9

339

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

6.9

441

3402

J01MA14

ATC

moxifloxacin; systemic

1.3

6.9

403

3069

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.0

6.9

319

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

1.7

6.9

120

716

ZXD20

NOMESCO Finland

Day surgery

1.3

6.9

566

4515

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.9

1912

17183

Z01.2

ICD-10 Finland

Dental examination

1.2

6.8

2352

21473

H81.3

ICD-10 Finland

Other peripheral vertigo

1.7

6.8

127

770

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

6.8

445

H05.2

ICD-10 Finland

Exophthalmic conditions

4.1

6.8

R13

ICD-10 Finland

Dysphagia

1.4

6.8

327

2415

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

6.8

127

772

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

6.8

266

1898

U02

ICPC

Urinary frequency/urgency

1.2

6.8

701

5745

25300

ICD-8 Finland

Diseases of pituitary gland, Aeromegalia

40.1

6.8

E22.88

ICD-10 Finland

Other hyperfunction of pituitary gland

40.1

6.8

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.7

6.7

126

P29

ICPC

Psychological sympt/compl other

1.4

6.7

300

2189

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

6.7

213

1461

ACC51

NOMESCO Finland

Release of median nerve

1.4

6.7

345

2578

AA4WT

NOMESCO Finland

Selective blood sample from sinus petrosus inferior

22.5

6.7

D44.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pineal gland

22.5

6.7

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

1.8

6.7

513

M02AA10

ATC

ketoprofen; topical

1.2

6.7

742

6130

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

6.7

528

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.8

6.6

499

A07AA02

ATC

nystatin; oral

1.4

6.6

253

1796

M10.9

ICD-10 Finland

Gout, unspecified

1.4

6.6

306

2247

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

6.6

393

3000

S20.2

ICD-10 Finland

Contusion of thorax

1.4

6.6

233

1631

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1.7

6.6

124

755

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

1.9

6.6

443

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.4

6.6

169

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.6

6.6

148

942

H93.1

ICD-10 Finland

Tinnitus

1.4

6.6

322

2386

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

2.8

6.6

111

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

6.6

387

2950

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

6.5

482

3789

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

8.7

6.5

C07AB12

ATC

nebivolol; oral

1.6

6.5

133

826

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

6.5

302

2217

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.8

6.5

546

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

6.5

262

1878

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

6.5

192

1297

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.5

125

766

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.8

6.5

496

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

3.6

6.5

K61.0

ICD-10 Finland

Anal abscess

2.0

6.4

355

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

6.4

187

1261

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

6.4

132

823

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.6

6.4

128

792

UJF32, ,

SPAT

1.5

6.4

163

1068

C10AX09

ATC

ezetimibe; oral

1.2

6.4

829

6959

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

6.4

937

7962

JN3AE, ,

SPAT

1.5

6.4

178

1189

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.0

6.4

335

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.0

6.4

301

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.0

6.4

349

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.5

6.4

209

1443

G44.0

ICD-10 Finland

Cluster headache syndrome

2.2

6.4

235

R06AX22

ATC

ebastine; oral

1.2

6.4

780

6510

A11

ICPC

Chest pain NOS

1.3

6.4

407

3140

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.4

366

2781

ZX050

NOMESCO Finland

Stereotactic radiotherapy

2.4

6.3

172

N05BA12

ATC

alprazolam; oral

1.3

6.3

441

3441

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

1.9

6.3

420

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

6.3

204

1404

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.7

6.3

119

725

M79.1

ICD-10 Finland

Myalgia

1.2

6.3

699

5771

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

6.3

337

2532

SPAT1097

SPAT

Recording of ECG

1.2

6.3

650

5324

R01AD12

ATC

fluticasone furoate; nasal

1.2

6.3

1492

13222

J01FA15

ATC

telithromycin; oral

1.3

6.3

439

3428

D33.7

ICD-10 Finland

Benign neoplasm: Other specified parts of central nervous system

9.2

6.3

T83

ICPC

Overweight

1.7

6.3

575

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

2.1

6.3

256

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

1.8

6.3

436

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.5

6.3

162

1065

25200

ICD-8 Finland

Diseases of parathyroid gland, Hyperparathyroidism

18.0

6.3

G04CA01

ATC

alfuzosin; oral

1.3

6.3

508

4045

2533A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]

+∞

6.2

D352, E2300,

ICD-10 Finland

+∞

6.2

2534

FHL

Remove both eggs

+∞

6.2

E220, D352,

ICD-10 Finland

+∞

6.2

E260, D350,

ICD-10 Finland

+∞

6.2

C75.1

ICD-10 Finland

Malignant neoplasm: Pituitary gland

+∞

6.2

PA5DT

NOMESCO Finland

Embolisation of a tumor of carotis externa area

+∞

6.2

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.2

905

7680

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

6.2

385

2955

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.0

6.2

338

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.0

6.2

345

25310

ICD-8 Finland

Diseases of pituitary gland, Panhypopituitarismus

26.7

6.2

L12

ICPC

Hand/finger symptom/complaint

1.2

6.2

821

6903

OAB93, ,

SPAT

1.4

6.2

266

1928

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.2

149

964

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.2

1049

9033

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

2.5

6.2

144

N05CD07

ATC

temazepam; oral

1.3

6.2

470

3713

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.7

6.1

102

601

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

6.1

320

2395

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

2.0

6.1

326

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.3

6.1

181

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.0

6.1

333

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.1

262

1899

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.4

6.1

295

2181

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

1.7

6.1

557

C07AB03

ATC

atenolol; systemic

1.4

6.1

230

1630

ENB99

NOMESCO Finland

Other excision of pharynx and adjacent structures

7.7

6.1

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

2.6

6.1

133

XQ848

NOMESCO Finland

Dermatological photography

1.6

6.1

128

802

PA6AD

NOMESCO Finland

CT of neck arteries

1.5

6.1

173

1161

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

2.8

6.1

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

1.8

6.1

426

D38.58

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other respiratory organ

12.5

6.1

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

6.1

221

1557

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

6.1

341

2582

K80.8

ICD-10 Finland

Other cholelithiasis

1.9

6.1

412

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.5

6.1

162

1073

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

6.1

258

1869

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.5

6.1

153

1001

GD1LA

NOMESCO Finland

2.0

6.0

321

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.3

6.0

362

2767

T07

ICPC

Weight gain

1.9

6.0

370

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

1.8

6.0

420

C03DB01

ATC

amiloride; oral

6.7

6.0

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

6.0

141

907

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(37021550) Renin [Units/volume] in Plasma --upright

215

26.85

312.78

1.3

61.60

77.82

mu/l

0.33

160

(43055514) Macroprolactin [Presence] in Serum or Plasma

275

36.47

307.65

1.9

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1439

641

29.39

307.65

1.5

1.3

0.66

3.38

nmol/l

0.49

1412

613

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1279

624

25.91

307.65

1.4

1.3

390.11

309.24

pmol/l

0.52

1193

524

(3020911) Cortisol [Moles/time] in 24 hour Urine

443

142

33.65

307.65

2.0

1.2

129.41

270.69

nmol/24h

0.33

443

142

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

234

27.34

307.65

1.3

1.1

267.89

327.57

pmol/l

0.64

171

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1200

292

51.36

307.65

3.3

1.6

17.00

19.08

nmol/l

3.29

1183

273

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1225

549

27.91

307.65

1.5

1.3

—

nmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

371

205

19.25

307.65

1.2

1.4

2.67

4.89

umol/l

11.43

343

176

(3009214) Lutropin [Units/volume] in Serum or Plasma

805

1337

6.82

307.65

2.0

1.3

8.07

11.11

u/l

6.80

661

1082

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

665

216

34.58

307.65

2.1

1.5

4.33

3.92

nmol/l

0.10

584

166

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1492

665

29.71

307.65

1.5

1.3

0.23

0.31

nmol/l

0.43

116

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

457

503

9.77

307.65

4.1

1.4

447.85

335.93

mu/l

1.29

431

388

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1306

550

30.23

307.65

1.5

1.3

0.21

nmol/l

0.02

1028

436

(3011985) Renin [Units/volume] in Plasma

1365

665

26.42

307.65

1.5

59.17

70.22

mu/l

0.38

1297

590

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3043

5047

11.41

307.65

4.2

2.2

312.28

382.77

nmol/l

40.54

2900

4682

(3021387) Prolactin [Units/volume] in Serum or Plasma

1410

1535

11.76

307.65

4.8

1.4

376.64

294.09

mu/l

3.37

1374

1393

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

518

126

44.98

307.65

3.9

1.5

0.99

1.01

ug/l

0.05

506

118

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1144

4230

3.12

230.32

4.7

2.2

11.63

13.26

nmol/l

9.71

1070

3820

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4068

27723

2.51

226.67

9.7

7.4

1.21

mmol/l

0.67

3624

23996

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3626

24837

2.20

179.00

8.1

6.8

1.21

mmol/l

0.32

3449

22997

(3023323) Follitropin [Units/volume] in Serum or Plasma

754

2512

3.30

178.18

1.9

1.4

22.43

30.48

iu/l

9.10

622

2165

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

335

641

5.48

166.64

3.8

3.4

4.77

14.24

nmol/l

0.56

325

622

(3013826) Glucose [Moles/volume] in Serum or Plasma

4285

31929

2.26

163.62

6.5

5.2

6.74

6.69

mmol/l

0.80

4167

30309

(3002079) Sodium [Moles/time] in 24 hour Urine

196

232

8.70

153.05

1.3

1.2

171.18

158.88

mmol/24h

0.94

196

232

(3033923) Metanephrine [Moles/time] in 24 hour Urine

137

14.44

151.14

1.3

1.1

0.80

0.70

umol/24h

0.32

(3024561) Albumin [Mass/volume] in Serum or Plasma

3507

24763

2.03

146.18

5.8

5.2

35.57

35.67

g/l

0.55

3362

23256

(3018418) pH of Serum or Plasma

2625

16803

2.01

143.84

5.0

4.4

7.40

0.14

1919

12049

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

856

3457

2.73

141.66

3.5

4.40

4.46

pmol/l

1.05

796

3098

(3032080) INR in Blood by Coagulation assay

3496

25152

1.96

132.11

14.9

1.22

1.24

inr

2.40

2983

20930

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3866

28841

1.99

130.67

6.9

10.66

11.42

umol/l

3.41

3733

27569

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

211

326

6.68

130.46

1.4

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4982

41135

2.37

124.71

6.7

4.5

14.90

14.78

pmol/l

2.82

4749

37889

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

318

773

4.29

118.22

1.9

1.4

0.32

0.37

nmol/l

0.68

226

584

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4968

41337

2.29

115.86

10.0

8.6

80.12

79.09

u/l

0.73

4820

39322

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

476

1547

3.26

115.45

2.9

1.8

41.46

42.26

nmol/l

0.23

470

1497

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

405

1191

3.58

115.04

3.0

1.8

172.58

204.19

pmol/l

7.28

384

1125

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1241

6545

2.14

110.29

7.4

7.9

5.20

5.09

kpa

3.69

1208

6295

(3027801) Oxygen [Partial pressure] in Arterial blood

1239

6541

2.13

109.77

7.4

7.9

12.98

12.43

kpa

2.57

1200

6292

(3014576) Chloride [Moles/volume] in Serum or Plasma

1393

7705

2.06

108.86

6.7

7.4

104.51

104.35

mmol/l

0.58

1393

7700

(3019977) pH of Arterial blood

1235

6541

2.12

108.33

7.4

8.0

7.41

7.42

0.36

708

3553

(3003396) Base excess in Arterial blood by calculation

1224

6492

2.12

106.80

7.4

7.9

1.03

0.92

mmol/l

0.45

1003

5353

(3013650) Neutrophils [#/volume] in Blood by Automated count

3982

31160

1.86

102.63

9.6

10.1

4.41

4.10

e9/l

10.83

3463

27010

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3391

25425

1.79

99.05

3.2

2.8

—

estimate

—

(3010838) Calcium [Moles/time] in 24 hour Urine

346

1014

3.56

98.56

2.1

1.9

5.65

4.91

mmol/24h

2.64

304

904

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1321

7397

2.01

98.50

6.3

1.01

1.04

mmol/l

2.93

1249

6889

(3008295) Osmolality of Serum or Plasma

259

633

4.23

95.42

2.2

1.4

283.48

276.60

mosm/kgh2o

4.75

232

480

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

741

3392

2.36

91.77

7.6

9.9

24.25

24.27

mmol/l

0.08

733

3335

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3320

25080

1.74

91.08

3.1

2.5

75.96

77.99

nmol/l

4.37

3092

22748

(3033658) Prothrombin time (PT) actual/Normal

2111

14044

1.78

90.69

4.4

4.2

92.48

90.00

4.47

2060

13751

(3019069) Monocytes/Leukocytes in Blood

3379

25671

1.74

90.65

7.1

6.8

8.68

8.86

3.35

3217

24076

(3006504) Eosinophils/Leukocytes in Blood

3372

25619

1.74

90.28

7.0

6.7

2.76

2.84

1.30

3213

24006

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

875

4326

2.20

90.03

4.8

3.9

95.55

90.60

ng/l

0.71

779

3724

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2499

17483

1.75

89.85

3.2

2.7

67.49

64.90

u/l

0.10

2349

16246

(3022096) Basophils/Leukocytes in Blood

3365

25614

1.73

88.87

7.1

6.8

0.67

0.68

0.99

3206

23979

(3026782) Osmolality of Urine

1673

10474

1.83

87.37

3.3

3.0

519.39

526.46

mosm/kgh2o

0.65

1509

9214

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4709

39689

1.93

86.48

5.3

4.5

13.05

12.18

mm/h

3.79

4512

37214

(4035726) Immunohistochemistry procedure

954

4961

2.10

85.90

1.3

1.4

—

(3002030) Lymphocytes/Leukocytes in Blood

3412

26214

1.72

85.72

7.0

6.7

27.21

27.68

1.74

3274

24829

(3018010) Neutrophils/Leukocytes in Blood

3361

25745

1.71

85.10

6.9

6.6

58.13

57.37

3.36

3248

24597

(3006315) Basophils [#/volume] in Blood

3579

27970

1.71

83.35

6.6

6.5

0.04

e9/l

1.33

3064

23949

(3044640) Blood type and Crossmatch panel - Blood

2507

17815

1.71

83.23

2.8

2.5

—

(3023368) Bacteria identified in Blood by Culture

2189

15010

1.73

82.63

4.6

4.5

—

(3013115) Eosinophils [#/volume] in Blood

3658

28809

1.71

82.27

6.9

6.7

0.19

e9/l

0.05

3185

25102

(3001604) Monocytes [#/volume] in Blood

3564

27891

1.70

81.88

6.7

6.5

0.60

0.59

e9/l

3.61

3042

23882

(3019198) Lymphocytes [#/volume] in Blood

3619

28488

1.70

80.84

6.7

6.6

1.95

1.90

e9/l

1.01

3178

24999

(3002582) Erythrocytes [#/volume] in Urine

2505

17955

1.69

79.36

3.9

3.5

108.21

76.88

e6/l

0.29

1963

13696

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

752

3680

2.20

78.71

6.6

8.4

24.61

24.85

mmol/l

1.11

746

3665

(3016502) Oxygen saturation in Arterial blood

1049

5828

1.97

77.97

8.0

8.3

95.80

95.69

0.23

1024

5624

(3018095) Leukocytes [#/volume] in Urine

2763

20427

1.66

76.94

4.6

4.1

95.35

98.07

e6/l

0.05

2029

14400

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

12.07

73.72

3.5

2.7

99.96

85.45

pmol/l

0.15

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5387

48363

2.34

73.30

7.3

5.5

1.72

1.91

mu/l

24.36

5098

44894

(3002173) Hemoglobin [Mass/volume] in Arterial blood

976

5441

1.95

71.24

8.3

8.8

123.60

121.18

g/l

3.23

955

5308

(3031040) Bacteria [#/volume] in Urine by Automated count

4200

34966

1.70

70.66

5.7

4.8

1546.05

1811.11

e6/l

0.12

455

(3021589) Normoblasts [#/volume] in Blood

3117

24075

1.63

70.54

14.0

11.9

0.01

0.00

e9/l

0.41

2556

19547

(3030467) Casts [#/volume] in Urine by Automated count

2194

15557

1.65

69.89

3.7

3.3

0.40

0.41

e6/l

0.05

1668

11406

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1967

13596

1.67

68.99

2.7

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5689

52642

3.40

68.87

28.7

19.3

139.78

139.70

mmol/l

1.61

5665

51686

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2369

17207

1.63

68.05

2.4

2.2

190.28

214.26

u/l

0.71

2266

16284

(3023103) Potassium [Moles/volume] in Serum or Plasma

5690

52746

3.35

66.86

28.9

19.5

3.95

3.97

mmol/l

9.56

5660

51696

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1312

8205

1.77

65.81

2.8

2.7

21.07

22.59

4.16

1244

7668

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1470

9536

1.72

64.58

3.5

0.81

mmol/l

0.08

1402

8987

(3000991) Gas panel - Venous blood

870

4818

1.95

64.22

8.7

9.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

12.48

64.09

1.2

1.1

2.09

1.63

umol/24h

1.99

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5577

51317

2.65

63.50

22.6

16.6

24.07

24.04

mg/l

0.02

5014

42467

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1387

8913

1.73

62.79

2.8

2.6

2.34

2.32

g/l

0.75

1302

8286

(3037467) Urinalysis macro (dipstick) panel - Urine

4292

36421

1.66

61.89

5.5

4.7

1.51

2.91

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1458

9559

1.70

61.07

2.9

2.7

12.35

13.03

umol/l

3.15

1385

8961

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2012

14404

1.60

59.10

2.7

2.4

2.95

2.80

mg/l

1.91

1787

12497

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5444

49888

2.21

57.04

23.1

16.1

80.76

80.66

ml/min/173m2

0.13

5224

46311

(3026008) Bacteria identified in Urine by Culture

2232

16549

1.56

55.43

3.7

3.3

—

(36304419) Bacteria [Presence] in Urine

2034

14784

1.57

55.03

3.6

3.3

0.40

309.30

estimate

0.62

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2444

18528

1.55

54.72

3.3

3.4

33.70

35.03

u/l

0.22

2324

17498

(3000850) Epithelial cells [#/volume] in Urine

1770

12475

1.60

54.54

3.1

2.8

6.07

5.55

e6/l

0.67

1637

11400

(40768804) Tissue Pathology biopsy report

2816

22067

1.53

53.81

2.4

2.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2208

16446

1.55

53.09

3.3

3.2

1542.37

1283.24

ng/l

1.08

1944

14210

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3036

24416

1.50

49.70

2.4

2.1

94.62

96.40

pmol/l

1.24

1714

12847

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

610

3250

1.98

49.68

8.8

10.4

16.34

16.00

2.13

592

3127

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1280

8562

1.63

47.87

2.0

2.1

29.44

29.64

0.45

1248

8341

(3010370) Gastrin [Moles/volume] in Serum or Plasma

8.26

47.86

3.4

1.8

40.27

36.27

pmol/l

0.13

(3014111) Lactate [Moles/volume] in Serum or Plasma

846

5068

1.78

47.61

7.5

7.9

1.25

1.32

mmol/l

1.21

829

4976

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

646

3583

1.90

46.56

8.8

10.2

0.62

0.63

0.31

646

3560

(3014007) Fractional oxyhemoglobin in Arterial blood

665

3731

1.88

46.24

8.7

10.0

94.06

94.07

0.00

665

3720

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

661

3717

1.88

45.61

8.7

9.9

1.33

1.29

0.46

661

3697

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3119

25479

1.48

45.52

3.7

3.1

131.31

126.96

ug/l

0.33

2935

23845

(3015377) Calcium [Moles/volume] in Serum or Plasma

2470

19273

1.49

45.45

3.6

2.37

2.35

mmol/l

3.96

2263

17518

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1351

9271

1.59

45.08

2.1

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1518

10707

1.56

44.95

4.3

3.9

226.46

473.31

ng/l

1.51

1157

8360

(3009261) Glucose [Presence] in Urine by Test strip

3468

28979

1.48

44.76

4.4

4.0

0.00

0.25

estimate

0.73

817

5712

(3021447) Carbon dioxide [Partial pressure] in Venous blood

897

5599

1.71

43.33

4.7

3.8

5.83

5.82

kpa

0.13

872

5464

(3003181) Sodium [Moles/volume] in Urine

267

1072

2.56

43.24

1.6

1.4

71.63

61.29

mmol/l

2.97

233

870

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1009

6510

1.66

42.99

2.7

2.9

7.00

8.19

umol/l

0.94

871

5740

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1294

8886

1.58

42.72

3.4

3.2

3.12

2.53

e6/l

1.05

644

4283

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2584

20510

1.46

42.67

4.4

3.8

59.28

72.51

ng/l

0.16

1893

14308

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5318

49116

1.86

42.46

8.2

6.5

40.11

39.25

mmol/mol

10.29

5087

46065

(3021601) Nitrite [Presence] in Urine by Test strip

3397

28461

1.46

41.87

4.4

4.0

0.00

estimate

1.34

868

5923

(3012544) pH of Venous blood

902

5693

1.69

41.68

4.8

3.9

7.38

0.57

534

3236

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

634

3626

1.84

41.26

4.3

3.7

5.22

5.15

kpa

1.36

614

3483

(3009508) Creatinine [Moles/volume] in Urine

2442

19260

1.46

41.22

3.8

3.5

7.44

7.45

mmol/l

0.05

2117

16288

(3035350) Ketones [Presence] in Urine by Test strip

3421

28779

1.45

40.71

4.4

4.0

2.78

4.01

estimate

0.24

881

6092

(3020682) Albumin/Creatinine [Ratio] in Urine

2357

18502

1.46

40.59

4.6

4.2

9.92

8.59

mg/mmol

0.55

1582

11430

(3002032) Base excess in Venous blood by calculation

865

5461

1.68

39.78

4.8

3.9

1.93

1.86

mmol/l

0.18

752

4804

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4085

35667

1.47

39.14

4.0

3.4

54.38

48.37

u/l

3.20

3899

33501

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

475

2516

1.97

39.02

6.0

5.1

1.67

1.61

0.61

455

2365

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1660

12237

1.50

39.00

1.9

1.8

1.12

1.25

mg/l

1.19

1304

9514

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

862

5482

1.67

38.45

2.3

0.22

0.21

g/l

3.36

812

5138

(3015235) Bicarbonate [Moles/volume] in Capillary blood

393

1965

2.07

37.91

3.7

3.0

25.06

24.86

mmol/l

0.42

386

1935

(3009343) pH of Capillary blood

607

3517

1.81

37.71

4.2

3.7

7.42

0.03

529

2909

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

857

5468

1.66

37.69

2.7

2.5

68.70

48.97

u/l

0.30

746

4608

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

720

4390

1.73

37.50

4.2

1.23

mmol/l

0.41

664

3800

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

147

5.22

37.27

1.5

1.6

0.47

0.38

ug/l

0.70

104

(3002256) Pathology report gross observation

1091

7420

1.58

36.87

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2045

15865

1.44

36.35

1.8

1.7

20.13

20.32

nmol/l

0.20

1792

13463

(40768797) Stomach Pathology biopsy report

1140

7873

1.56

35.91

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5355

49980

1.79

35.47

6.1

5.3

6.04

5.94

mmol/l

7.46

5055

46084

(3012516) Albumin [Mass/volume] in Urine

2292

18219

1.42

35.36

3.9

3.5

49.76

47.71

mg/l

0.16

1575

11519

(3020630) Protein [Mass/volume] in Serum or Plasma

756

4775

1.67

34.36

2.5

2.7

66.04

66.38

g/l

0.63

695

4402

(3007164) IgA [Mass/volume] in Serum or Plasma

1490

10980

1.48

34.24

1.5

2.41

2.43

g/l

0.12

924

6794

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5714

54638

2.56

34.16

31.2

21.5

79.36

77.09

umol/l

3.78

5698

54042

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

531

3049

1.82

33.85

3.9

3.5

2.25

1.89

mmol/l

1.53

398

2281

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

270

1229

2.25

33.03

1.4

91.22

27.56

e6/l

0.57

184

897

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1349

9805

1.49

33.03

3.2

3.0

1.18

1.11

e6/l

0.21

716

5218

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

272

1248

2.24

32.64

1.4

1.5

1739.21

1121.65

e6/l

0.45

205

971

(3042936) Bacteria identified in Isolate by Culture

1121

7883

1.52

32.08

2.3

2.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

786

5113

1.62

31.61

7.8

9.77

9.83

mmol/l

0.07

751

4911

(3007930) Methemoglobin/Hemoglobin.total in Blood

423

2314

1.89

31.41

6.4

5.4

0.84

0.88

1.05

404

2174

(3027945) Reticulocytes/Erythrocytes in Blood

936

6372

1.56

30.96

2.9

2.6

1.83

1.80

0.38

844

5688

(3028626) Oxygen [Partial pressure] in Capillary blood

282

1346

2.15

30.67

3.6

3.2

8.18

8.16

kpa

0.09

277

1316

(3021440) Promyelocytes/Leukocytes in Blood

750

4874

1.62

30.20

4.5

4.6

0.09

0.13

0.73

205

1335

(3002179) Metamyelocytes/Leukocytes in Blood

748

4866

1.62

29.98

4.3

0.65

0.70

0.25

220

1469

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

944

6485

1.54

29.89

4.2

4.7

230.85

243.04

u/l

2.31

890

6173

(3015736) pH of Urine

2738

22864

1.37

29.70

3.7

3.5

6.17

6.23

1.83

1483

12776

(3017181) Myelocytes/Leukocytes in Blood

774

5093

1.60

29.56

4.4

4.5

0.95

0.93

0.07

227

1548

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1635

12553

1.42

29.33

1.4

1.3

1.23

1.74

u/ml

1.26

427

3408

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

183

739

2.52

29.31

2.0

1.3

19.70

29.65

u/l

4.33

165

607

(3024354) Oxygen [Partial pressure] in Venous blood

713

4640

1.61

28.45

3.5

3.2

4.65

4.54

kpa

0.74

693

4518

(3046904) Somatotropin [Units/volume] in Serum or Plasma

64.30

27.92

4.3

1.0

3.25

2.62

mu/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

854

5871

1.53

26.70

3.9

4.3

26.18

22.83

ug/l

0.11

698

4762

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4672

42867

1.44

26.57

28.0

20.4

13.82

13.64

17.53

4649

42318

(3037522) Nuclear Ab [Titer] in Serum

1096

7938

1.47

26.55

1.4

525.32

529.36

titre

0.02

233

1730

(3008152) Bicarbonate [Moles/volume] in Arterial blood

552

3425

1.67

26.53

8.1

6.9

25.09

24.52

mmol/l

3.08

531

3269

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

980

6946

1.49

26.47

1.9

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1899

15181

1.37

26.11

3.9

3.4

0.75

0.16

estimate

0.59

684

4739

(3014051) Protein [Presence] in Urine by Test strip

1923

15404

1.37

26.11

3.2

3.0

0.05

0.03

359

(3021901) Oxygen saturation in Capillary blood

241

1153

2.14

26.07

3.4

3.1

90.38

89.94

0.57

236

1123

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

281

1424

2.02

26.06

1.3

522.63

547.72

mg/l

0.39

267

1354

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

635

4106

1.61

25.89

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

145

556

2.65

25.85

1.5

—

(3025159) Blasts/Leukocytes in Blood

735

4925

1.56

25.74

4.8

4.7

0.73

0.24

0.48

184

1259

(3022145) Colonoscopy Study observation

922

6497

1.50

25.54

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1833

14612

1.37

25.52

2.9

2.8

351.49

340.28

umol/l

4.76

1635

12916

(3023520) Reticulocytes [#/volume] in Blood

733

4932

1.56

25.17

3.0

2.7

71.98

69.90

e9/l

0.85

542

3590

(3005719) IgG [Mass/volume] in Serum or Plasma

666

4384

1.59

25.17

2.8

2.9

10.22

10.53

g/l

1.13

616

4039

(3027273) Bicarbonate [Moles/volume] in Venous blood

417

2429

1.77

25.16

4.9

3.4

25.28

25.29

mmol/l

0.01

400

2350

(3023410) Appearance of Cerebral spinal fluid

143

553

2.63

25.08

1.5

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1440

11065

1.40

24.98

3.0

2.47

2.45

mmol/l

4.59

1312

9929

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.09

24.97

1.6

1.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

176

4.01

24.94

1.5

14.66

15.36

pmol/l

0.40

151

(3013512) EKG study

2286

18927

1.34

24.60

4.1

3.7

0.80

0.76

—

(3016038) Potassium [Moles/volume] in Urine

112

387

2.93

24.33

1.3

1.2

34.50

35.43

mmol/l

0.16

105

336

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

413

2435

1.75

23.88

2.0

1.9

38.76

39.64

u/l

0.38

369

2182

(3004119) Hemoglobin [Mass/volume] in Venous blood

547

3477

1.63

23.84

3.5

3.2

128.87

129.26

g/l

0.14

520

3374

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

225

1086

2.11

23.80

1.7

2.0

1.03

0.86

nmol/l

2.01

202

930

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2362

1.76

23.79

2.5

2.3

4.19

4.21

g/l

0.27

365

2177

(40760892) CBC W Ordered Manual Differential panel - Blood

1557

12202

1.38

23.77

4.6

4.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2363

1.76

23.75

2.5

2.3

7.39

7.43

g/l

0.16

363

2176

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

2361

1.75

23.55

2.5

2.3

3.61

3.71

g/l

0.75

365

2177

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

796

5557

1.50

22.89

3.3

3.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3574

31726

1.32

22.83

3.1

2.9

—

(3047181) Lactate [Moles/volume] in Blood

307

1679

1.87

22.75

7.5

6.0

1.27

1.32

mmol/l

0.45

274

1477

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

909

6525

1.46

22.72

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

248

1264

2.00

22.65

1.2

1.3

3.66

3.78

mmol/l

1.03

231

1192

(40758558) Short blood count panel - Blood

2033

16701

1.33

22.51

6.7

6.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

340

1931

1.81

22.32

2.2

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5635

54255

1.90

22.16

15.6

12.6

27.26

26.18

u/l

2.38

5540

52751

(3022313) Gas panel - Capillary blood

407

2449

1.71

21.85

4.4

3.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

360

2098

1.76

21.66

2.3

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

377

2230

1.74

21.53

2.5

2.3

2.87

2.91

g/l

0.33

339

2046

(3012565) Volume of 24 hour Urine

285

3.12

21.44

1.7

2.4

2047.84

1917.44

0.62

258

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

349

2024

1.77

21.35

2.4

2.3

9.70

10.23

g/l

1.53

309

1823

(3010421) pH of Blood

312

1764

1.81

20.79

3.3

3.9

7.41

0.18

307

1751

(3034860) Kappa light chains.free [Mass/volume] in Serum

335

1945

1.77

20.41

3.1

3.5

48.28

79.38

mg/l

0.56

280

1655

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

7.47

20.34

3.2

2.7

250.02

99.53

pmol/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

334

1943

1.76

20.21

3.1

3.5

36.23

54.99

mg/l

1.37

280

1653

(3019309) Folate [Moles/volume] in Red Blood Cells

1171

9013

1.37

19.40

1.8

1.7

1094.32

1164.24

nmol/l

1.90

927

6869

(46235355) HIV 1 and 2 tests - Meaningful Use set

1154

8865

1.38

19.34

1.9

—

(3019225) pH of Specimen

740

5257

1.47

19.30

6.9

4.3

7.37

7.35

0.88

614

3744

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5145

48688

1.45

19.23

4.9

4.4

1.42

1.29

mmol/l

25.53

4807

44898

(36660697) Celiac disease serology panel - Serum

641

4429

1.50

19.20

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5432

51989

1.58

19.12

6.7

5.9

2.63

2.71

mmol/l

10.44

5143

48555

(3007461) Platelets [#/volume] in Blood

5728

55697

2.05

18.15

35.5

25.2

257.05

251.63

e9/l

7.85

5668

54635

(3000570) Elastase.pancreatic [Mass/mass] in Stool

302

1762

1.75

18.10

1.5

1.4

249.81

275.62

ug/g

1.41

169

1049

(3035941) MCH [Entitic mass]

5728

55703

2.05

18.05

35.3

25.0

30.18

30.35

10.88

5712

55148

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5728

55704

2.05

18.03

35.3

25.1

91.00

91.21

3.04

5712

55149

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5338

50980

1.50

18.01

5.8

5.1

1.39

1.47

mmol/l

43.36

5041

47498

(3000963) Hemoglobin [Mass/volume] in Blood

5729

55719

2.05

18.00

35.7

25.3

134.37

135.00

g/l

2.58

5711

55180

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5728

55708

2.04

17.96

36.1

25.6

40.34

40.81

1.56

5711

55126

(3026361) Erythrocytes [#/volume] in Blood

5728

55709

2.04

17.94

35.4

25.1

4.49

4.48

e12/l

1.02

5654

54464

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

297

1729

1.76

17.94

3.1

3.3

3.97

2.82

ratio

0.31

166

965

(1616796) Gas panel - Central venous blood

227

1217

1.90

17.93

3.8

4.0

—

(3010813) Leukocytes [#/volume] in Blood

5728

55714

2.04

17.86

35.5

25.2

7.15

6.70

e9/l

21.13

5655

54455

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

509

3401

1.54

17.80

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

406

2575

1.62

17.76

1.6

1.7

1.63

1.55

g/l

0.95

358

2225

(3048689) Calprotectin [Mass/mass] in Stool

937

7062

1.39

17.46

2.3

2.4

128.38

135.42

ug/g

0.27

741

5652

(3007853) Bacteria identified in Skin by Aerobe culture

860

6391

1.40

17.42

1.9

1.8

—

(3045716) Anion gap in Serum or Plasma by calculation

132

586

2.28

17.27

2.6

3.5

10.20

10.58

mmol/l

0.51

132

577

(3028026) IgM [Mass/volume] in Serum or Plasma

508

3427

1.53

16.98

1.7

2.0

1.13

1.33

g/l

2.26

469

3158

(3003694) ABO and Rh group [Type] in Blood

1822

15181

1.29

16.97

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

424

2749

1.58

16.92

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5355

51266

1.49

16.88

5.9

5.2

4.52

4.65

mmol/l

17.62

5094

48069

(3008037) Lactate [Moles/volume] in Venous blood

235

1301

1.84

16.80

3.3

3.0

1.49

1.59

mmol/l

1.00

224

1259

(3049717) Cytology report of Urine Cyto stain

328

2011

1.67

16.41

3.0

2.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

606

4278

1.46

16.20

3.2

3.0

193.61

180.53

ng/l

0.34

564

3912

(3039000) Anion gap in Blood by calculation

212

1164

1.85

15.58

9.0

7.1

10.88

11.29

mmol/l

1.12

193

1035

(3045424) Erythrocytes [Presence] in Urine

419

2762

1.56

15.54

2.4

2.2

0.10

0.30

estimate

0.31

144

875

(3018572) Chloride [Moles/volume] in Blood

212

1165

1.85

15.54

9.0

7.1

105.04

105.10

mmol/l

0.07

193

1036

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

261

1535

1.73

15.24

2.0

3.20

7.63

iu/l

0.64

636

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2460

21453

1.25

15.22

4.3

3.9

0.86

0.26

estimate

0.38

714

4895

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

329

2060

1.63

15.16

2.5

2.3

0.46

0.91

g/l

2.73

279

1784

(3017732) Neutrophils [#/volume] in Blood

926

7113

1.36

15.15

3.4

3.3

4.81

4.56

e9/l

0.32

800

6175

(3037756) Immunofixation for Serum or Plasma

209

1153

1.84

15.14

1.6

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

792

5949

1.38

14.90

1.7

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

287

1749

1.67

14.71

2.4

2.2

0.00

0.03

g/l

2.80

256

1582

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2611

22999

1.24

14.53

2.1

1.9

1.47

1.36

mmol/l

8.86

2214

19316

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

410

2736

1.54

14.39

4.7

3.9

46.87

47.69

0.26

401

2692

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

818

6218

1.37

14.25

1.8

1.51

1.47

0.76

712

5446

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

277

1693

1.67

14.05

2.4

2.2

0.00

g/l

-0.00

240

1490

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

113

516

2.21

13.90

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1858

15816

1.26

13.85

4.6

4.2

0.00

estimate

0.46

818

5505

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

260

1575

1.68

13.65

2.4

2.3

0.00

g/l

-0.00

240

1489

(3044242) Glucose [Moles/volume] in Arterial blood

308

2.55

13.30

2.0

2.1

7.91

8.21

mmol/l

0.29

308

(40761536) Microorganisms panel - Urine sediment

587

4272

1.42

13.23

4.7

4.1

—

(3024928) Oxygen saturation in Venous blood

239

1428

1.70

13.21

3.3

3.1

62.47

61.48

0.27

230

1392

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

318

2044

1.59

13.17

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

622

4577

1.40

13.16

2.9

2.5

0.28

0.46

e6/l

2.23

602

4381

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

275

2.64

13.13

1.8

1.5

—

(3012501) Base excess in Blood by calculation

195

1102

1.80

13.11

3.5

4.5

2.62

2.55

mmol/l

0.13

133

760

(3013290) Carbon dioxide [Partial pressure] in Blood

195

1103

1.79

13.07

3.5

4.5

5.03

5.02

kpa

0.08

190

1088

(3027315) Oxygen [Partial pressure] in Blood

196

1111

1.79

13.04

3.5

4.5

8.70

8.55

kpa

0.45

191

1095

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

322

2081

1.58

13.04

3.2

3.6

306.50

2697.99

u/ml

1.10

273

1798

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

252

1540

1.66

12.81

1.4

1.5

23.06

15.13

iu/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

269

1676

1.63

12.68

2.9

3.4

1.54

1.56

mg/l

0.18

249

1539

(3024980) IgG subclass 4 [Mass/volume] in Serum

178

992

1.82

12.54

1.5

1.6

0.72

0.77

g/l

0.32

136

770

(3052851) Hemolysis interference index of Serum or Plasma

246

1507

1.66

12.40

3.2

3.3

1.39

1.94

index

1.21

128

771

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1373

11417

1.26

12.23

1.8

1.7

9146257.87

35979104.59

pmol/l

2.71

1159

9564

(3003327) Ova and parasites identified in Stool by Light microscopy

297

1913

1.58

12.21

1.6

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

120

591

2.05

12.21

1.1

—

4.29

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

959

7637

1.31

12.01

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

407

2826

1.47

11.80

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

295

1913

1.57

11.79

2.4

2.7

—

(3045414) Leukocytes [Presence] in Urine

712

5448

1.35

11.77

2.3

2.2

0.02

0.01

estimate

0.33

178

1109

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

245

1523

1.64

11.68

2.0

11.54

11.74

mg/l

0.13

223

1422

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1267

10491

1.26

11.61

1.4

1.3

35.37

31.17

iu/ml

0.49

384

3184

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

305

2001

1.55

11.58

2.3

2.2

413.60

623.85

ug/l

0.79

290

1901

(3038515) Glucose [Moles/volume] in Venous blood

185

1072

1.75

11.46

3.7

3.2

7.46

7.50

mmol/l

0.06

175

1039

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1185

9749

1.27

11.44

1.3

10.90

12.08

u/ml

0.23

460

3800

(3009445) Proteinase 3 Ab [Units/volume] in Serum

352

2390

1.50

11.40

1.5

1.6

5.64

15.45

iu/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

273

1753

1.58

11.39

1.6

1.7

0.25

0.24

g/l

1.27

249

1664

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

250

1575

1.61

11.30

1.6

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

361

2.29

11.09

2.5

1.8

126.83

113.72

ng/l

0.30

361

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

291

1909

1.55

11.07

4.4

3.8

25.20

24.88

mmol/l

1.10

275

1760

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

417

2946

1.45

11.05

3.2

2.9

1.41

1.22

2.92

411

2926

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

508

3721

1.40

11.00

1.2

146.92

142.73

u/ml

0.07

159

1384

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

253

2.55

10.96

1.3

48.00

65.89

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

331

2253

1.50

10.61

2.3

1.9

1.76

2.24

ug/l

0.47

295

2020

(3017354) Segmented neutrophils/Leukocytes in Blood

114

582

1.98

10.56

4.0

3.6

58.01

57.65

0.05

501

(3017569) Oxygen content in Arterial blood

325

2.32

10.54

2.1

2.4

16.29

16.17

0.10

325

(3023183) Ammonium ion [Moles/volume] in Plasma

202

1231

1.66

10.44

2.2

2.8

31.10

34.22

umol/l

1.23

184

1121

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

275

1807

1.55

10.40

1.5

1.7

1.24

1.20

g/l

1.13

253

1719

(3004809) Band form neutrophils/Leukocytes in Blood

158

908

1.76

10.12

4.1

3.6

1.42

1.62

0.32

135

812

(3025549) Creatine [Moles/time] in 24 hour Urine

5.28

10.10

1.6

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

273

1807

1.54

10.00

2.9

3.2

0.40

0.34

iu/ml

1.21

162

995

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

562

4254

1.35

9.93

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

214

1343

1.62

9.87

2.3

133.45

128.53

g/l

2.03

158

1041

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

590

4507

1.34

9.82

3.2

2.7

67.50

66.36

ml/min/173m2

0.18

290

1890

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

149

850

1.77

9.80

1.1

1133.65

13547.75

iu/ml

0.48

173

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

252

1657

1.54

9.53

2.2

2.6

3.82

3.57

g/l

1.85

240

1578

(3021879) Hepatitis B virus core Ab [Presence] in Serum

531

4012

1.36

9.49

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

194

1201

1.64

9.47

1.4

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1845

16182

1.20

9.45

6.3

5.6

1.95

2.78

ug/l

8.16

1707

14692

(3001556) Androgen free Index in Serum or Plasma

5.15

9.35

1.6

1.1

—

(3025941) Bacteria identified in Stool by Culture

395

2859

1.41

9.18

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

272

1834

1.51

9.16

2.9

3.2

860.57

445.54

mg/l

0.33

132

793

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

199

1253

1.61

9.08

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

242

1606

1.53

8.80

1.2

1356.67

831.00

titre

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

380

2.09

8.68

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

123

690

1.80

8.61

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

238

1583

1.52

8.57

2.4

2.5

185.15

194.82

0.94

227

1511

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

510

3911

1.33

8.26

2.6

2.5

13.22

21.98

au/ml

2.47

413

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

231

1545

1.52

8.12

2.3

2.1

10669.72

5064.28

u/l

0.85

604

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

418

2.00

8.09

1.1

37.56

41.49

mg/l

0.54

347

(3007566) Smooth muscle Ab [Titer] in Serum

239

1612

1.50

8.08

1.2

81.25

146.86

titre

0.95

153

(3003129) Base excess in Capillary blood by calculation

120

683

1.77

8.03

2.5

2.2

0.75

0.56

mmol/l

0.19

115

658

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

441

1.96

7.97

1.3

2.11

2.16

mmol/l

0.12

411

(3000494) Fungus identified in Specimen by Culture

833

6838

1.25

7.96

1.6

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

250

1711

1.48

7.87

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

246

1680

1.48

7.83

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

313

2243

1.42

7.73

1.6

0.33

0.31

mg/l

0.18

136

1046

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

471

3608

1.33

7.69

1.4

1.3

46.61

56.70

au/ml

0.33

253

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

249

1718

1.47

7.54

2.1

2.3

95.84

93.06

1.19

238

1655

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

1248

1.55

7.51

3.3

3.6

787.25

681.04

u/ml

0.06

173

1140

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1131

9655

1.21

7.42

3.6

3.3

0.79

0.76

ug/l

0.31

811

6375

(3036489) Thrombin time

292

2085

1.42

7.38

2.0

2.1

20.42

21.09

1.12

254

1841

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

405

1.96

7.36

1.1

247.46

269.56

mg/l

0.61

349

(3023511) Choriogonadotropin [Units/volume] in Urine

124

732

1.71

7.34

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

499

3882

1.31

7.31

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

313

2.09

7.19

1.4

1.37

1.26

nmol/l

0.35

227

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

288

2061

1.42

7.19

1.6

18.21

17.19

u/ml

0.10

475

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

105

596

1.78

7.14

1.3

1.2

48.81

61.14

u/l

2.43

527

(3005322) IgE [Units/volume] in Serum or Plasma

465

3595

1.32

7.13

1.3

154.54

229.12

u/ml

2.25

439

3345

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

396

2992

1.35

7.11

2.8

3.8

107.48

64.45

u/ml

0.24

380

2885

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

118

694

1.71

7.09

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

7.91

7.09

1.0

107.29

78.00

pmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

2.50

7.06

1.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

120

710

1.70

7.06

2.3

31.85

32.47

0.78

120

705

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

207

1396

1.50

7.05

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

350

2.01

7.02

1.4

1.2

84.57

89.97

u/l

0.22

299

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

160

1021

1.58

7.00

1.2

1.3

24.39

40.00

u/l

1.67

146

889

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1477

12983

1.18

6.97

4.9

4.5

21.48

21.90

0.49

756

6418

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

215

1466

1.48

6.94

1.4

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

311

2273

1.39

6.89

1.3

0.24

1.31

u/ml

3.34

193

(3004451) EKG impression Narrative

326

2.04

6.85

1.2

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1512

13337

1.18

6.83

3.8

0.11

0.16

—

141

(4027681) Cerebrospinal fluid IgG ratio and IgG index

307

2.06

6.78

1.2

0.56

0.59

ratio

0.33

176

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

923

1.59

6.44

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

161

1054

1.54

6.34

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

161

1054

1.54

6.34

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

337

1.97

6.28

1.3

1.2

22.53

24.36

u/l

0.12

281

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

303

2.02

6.27

1.1

1.26

1.17

u/l

0.20

141

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

200

1374

1.47

6.26

1.1

11.37

5.34

eliau/ml

0.45

156

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

115

698

1.66

6.20

1.8

2.0

31.75

23.51

ug/l

0.35

115

688

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

128

799

1.62

6.18

6.8

6.5

12.49

11.98

mg/l

0.58

115

753

(3043409) Potassium [Moles/volume] in Arterial blood

210

1468

1.45

6.02

4.4

4.1

3.80

3.89

mmol/l

2.25

210

1455

(3021788) Differential panel - Synovial fluid

158

1043

1.53

6.01

1.6

—

1.00

—

(3044927) Protein electrophoresis panel - Urine

538

1.74

6.00

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

261

2.08

5.99

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

249

1798

1.40

5.97

1.5

0.11

6.62

iu/ml

0.95

332

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

296

2.00

5.92

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

123

770

1.61

5.89

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

476

1.78

5.82

1.2

115.60

106.86

pmol/l

0.73

476

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

341

1.92

5.75

7.0

6.7

12.38

131.95

ug/l

1.09

213

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

183

1258

1.47

5.74

1.6

1.5

110.30

173.26

pmol/l

2.03

177

1231

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

144

942

1.54

5.73

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

531

1.72

5.71

4.7

4.1

—

(3000012) Reticulocyte production index

123

784

1.58

5.50

2.0

2.2

0.94

0.90

0.34

530

(3011288) Drugs identified in Urine by Screen method Nominal

171

1171

1.47

5.49

2.4

3.1

—

(4195642) Thrombophilia screening test

124

793

1.58

5.47

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

117

738

1.60

5.46

1.7

2.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

435

1.78

5.42

1.2

1.3

8.81

9.06

mmol/l

0.19

415

(3006922) Hepatitis E virus Ab [Presence] in Serum

443

1.77

5.40

1.1

—

(4062490) Immunoglobulin typing, IgG

602

1.66

5.36

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1294

1.44

5.33

1.4

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

111

697

1.60

5.30

2.2

2.4

1.26

1.30

g/24h

0.06

413

(3024139) IgG subclass 3 [Mass/volume] in Serum

100

612

1.64

5.29

1.4

1.3

0.34

0.40

g/l

1.13

446

(3028192) IgG subclass 2 [Mass/volume] in Serum

100

612

1.64

5.29

1.4

1.3

2.93

2.90

g/l

0.05

447

(3027135) IgG subclass 1 [Mass/volume] in Serum

100

613

1.64

5.26

1.4

1.3

6.71

6.76

g/l

0.05

446

(3006571) Granulocytes/Leukocytes in Synovial fluid

102

630

1.63

5.21

1.6

57.64

58.02

0.03

387

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

136

899

1.52

5.20

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

211

1519

1.40

5.19

1.5

1.6

—

(4024509) Urine culture

339

2626

1.31

5.19

2.0

—

(3042631) Mycobacterium sp identified in Specimen

117

748

1.58

5.19

2.6

2.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

1187

1.45

5.14

5.1

5.9

260.50

1783.92

iu/ml

0.64

176

(40768441) Liver Pathology biopsy report

431

1.75

5.01

1.4

—

(1002224) Polysomnography panel

327

2537

1.31

4.96

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

184

1308

1.42

4.89

1.2

1.3

22.37

42.98

u/ml

2.37

143

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

122

799

1.54

4.89

1.1

122.20

116.39

1.20

109

722

(3023420) DNA double strand Ab [Units/volume] in Serum

312

2412

1.31

4.86

1.6

1.8

6.19

6.75

iu/ml

0.16

573

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

179

1269

1.42

4.83

1.3

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

574

1.63

4.79

1.4

1.3

1.50

1.53

nmol/l

0.12

519

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

171

1205

1.43

4.78

2.0

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

550

4564

1.23

4.74

2.5

2.3

5.48

7.86

ug/l

2.14

490

4058

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

224

1659

1.36

4.68

1.3

2.13

4.79

u/ml

0.71

155

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

337

1.82

4.68

1.3

1.6

10.88

6.01

u/l

0.69

297

(3003329) Lymphocytes/Leukocytes in Synovial fluid

486

1.68

4.67

1.6

1.5

38.54

31.79

0.76

292

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

382

1.76

4.63

1.1

1.0

—

0.62

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

2.40

4.62

1.1

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

160

2.19

4.54

1.2

6.61

11.89

pmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

935

1.48

4.54

2.5

2.9

5139.90

1168.04

u/ml

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

104

2.51

4.53

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

207

1524

1.37

4.51

1.5

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.86

4.48

1.2

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.18

4.48

1.1

88.11

89.88

0.13

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

278

1.88

4.44

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

278

1.88

4.44

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

278

1.88

4.44

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

278

1.88

4.44

1.7

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

336

1.79

4.42

1.7

1.5

5.83

6.46

u/l

0.13

274

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

222

1661

1.35

4.37

1.3

10.01

6.98

u/ml

0.23

248

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

488

1.65

4.36

1.3

1.6

2.40

4.10

ug/l

1.82

410

(3012898) Urea [Moles/volume] in Urine

3.10

4.35

1.4

146.53

161.46

mmol/l

0.23

(4268621) Lupus anticoagulant assay

605

1.58

4.35

2.7

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

194

1424

1.37

4.32

1.8

1.6

13998.37

10724.37

e6/l

0.63

134

977

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

451

1.67

4.32

1.2

80.00

178.93

titre

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.26

4.29

1.2

1.3

34.10

37.78

umol/24h

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

253

1.90

4.28

2.1

2.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

167

1198

1.41

4.26

4.3

4.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

356

1.75

4.22

1.1

6.31

13.11

nmol/l

0.49

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

1118

1.42

4.19

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

160

2.13

4.14

1.1

1.3

90.78

89.71

0.05

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

472

1.64

4.13

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

472

1.64

4.13

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

472

1.64

4.13

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

523

4381

1.21

4.13

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

122

831

1.48

4.12

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

117

1700

0.68

4.10

1.1

0.63

ratio

0.01

235

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.08

4.08

1.4

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

505

1.61

4.07

6.1

5.3

238.81

56.70

u/ml

0.76

155

(3018333) Ribosomal P Ab [Presence] in Serum

436

1.66

4.06

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

251

1.88

4.05

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

182

2.04

4.03

1.1

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

223

1693

1.33

4.01

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

109

730

1.50

4.01

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

454

1.64

3.97

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

548

1.58

3.96

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

186

1377

1.36

3.96

1.3

2.20

4.49

u/ml

—

(3014271) Vancomycin [Susceptibility]

239

1.89

3.95

2.8

—

(3008898) HLA-B27 [Presence]

240

1847

1.31

3.93

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

114

774

1.48

3.93

1.1

1.51

1.52

g/l

0.07

107

700

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

341

2746

1.26

3.91

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

473

1.61

3.87

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

256

1.84

3.83

1.9

2.3

105.91

140.55

umol/l

0.54

138

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

126

878

1.44

3.82

1.1

0.29

0.82

—

(3016879) Cocaine [Presence] in Urine

206

1560

1.33

3.79

1.7

2.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.19

3.77

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

569

4847

1.19

3.77

2.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

716

1.49

3.77

1.5

1.4

—

(3025130) Human papilloma virus identified in Specimen

116

798

1.46

3.76

1.8

1.9

—

(3023419) Bacteria identified in Sputum by Culture

111

758

1.47

3.74

2.5

2.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

468

5556

0.83

3.71

1.9

2.0

3.56

3.47

ratio

0.84

358

4281

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

1196

1.37

3.69

2.2

2.4

184.86

105.80

ug/min

0.63

724

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.60

3.69

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

448

1.61

3.68

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

178

1325

1.35

3.68

1.7

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

498

1.57

3.60

3.4

2.9

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

333

4075

0.81

3.58

1.6

1.7

3.43

3.48

mmol/l

0.34

228

2810

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

150

2.07

3.56

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

468

1.59

3.56

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

468

1.59

3.56

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

157

2.04

3.54

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

118

2.21

3.50

1.3

1.4

1.23

1.17

mmol/l

1.90

118

(3014765) Yersinia sp identified in Stool by Organism specific culture

190

1442

1.33

3.48

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

142

1030

1.39

3.47

1.5

1.7

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

487

1.57

3.47

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

144

1048

1.38

3.45

2.1

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

122

864

1.42

3.43

1.4

1.2

1.76

3.92

u/ml

3.14

297

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

100

2.31

3.42

1.2

64.83

76.82

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

153

2.03

3.39

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

342

2803

1.23

3.39

1.9

2.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

238

1.81

3.37

1.2

1.1

83.47

321.06

ng/l

1.12

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

195

1.90

3.37

1.3

0.32

0.30

g/l

0.55

159

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.50

3.37

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

275

1.75

3.36

3.9

4.2

—

(3006653) Thiamine [Moles/volume] in Blood

298

1.72

3.34

1.3

134.49

136.15

nmol/l

0.10

298

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

154

2.02

3.34

1.3

277.99

428.74

ug/l

0.19

(3027008) Opiates [Presence] in Urine

217

1690

1.29

3.31

1.7

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

104

720

1.45

3.31

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

135

980

1.39

3.30

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

639

1.48

3.29

2.6

2.2

20.32

22.92

mg/l

0.29

229

(3006442) Creatine [Moles/volume] in Serum or Plasma

338

1.66

3.27

1.5

85.80

81.06

umol/l

0.40

338

(3000764) Benzodiazepines [Presence] in Urine

216

1685

1.29

3.26

1.7

2.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

189

1450

1.31

3.23

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

528

1.52

3.23

1.3

—

(3028300) Cannabinoids [Presence] in Urine

217

1700

1.29

3.18

1.7

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

186

1428

1.31

3.17

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1006

9069

1.13

3.14

1.7

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.96

3.13

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

207

1617

1.29

3.11

1.2

—

(40768800) Prostate Pathology biopsy report

144

1068

1.36

3.11

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

145

2.00

3.09

1.6

1.9

34.56

51.41

u/l

0.36

139

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

7.51

3.05

3.5

9.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

323

1.65

3.01

1.2

1.1

88.58

82.61

u/l

0.18

289

(44806118) Parainfluenza type 4 nucleic acid detection

102

722

1.42

2.93

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

102

722

1.42

2.93

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

102

722

1.42

2.93

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

102

722

1.42

2.93

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.18

2.92

1.3

1.2

91.00

82.30

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

141

1055

1.34

2.90

1.2

248.66

276.90

u/ml

0.53

653

(21494755) Public health laboratory ask at order entry panel

382

4510

0.84

2.89

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

137

1022

1.35

2.88

1.3

205.71

391.29

titre

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.96

2.84

1.1

—

(3000330) Specific gravity of Urine by Test strip

330

2752

1.21

2.81

3.7

3.3

1.02

ratio

0.96

299

2489

(3005988) Vibrio sp identified in Specimen by Organism specific culture

687

1.42

2.79

1.6

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.27

2.76

1.5

6.99

385513.87

nmol/l

0.72

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

148

1125

1.32

2.76

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

682

1.41

2.73

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

750

1.39

2.71

1.2

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

132

1.97

2.69

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

518

1.47

2.69

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

684

1.41

2.69

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

552

1.46

2.66

1.7

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

1106

1.32

2.65

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

208

1665

1.26

2.62

1.7

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

424

1.52

2.60

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

179

1409

1.28

2.59

1.1

3.58

3.98

0.23

186

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

114

843

1.36

2.57

1.4

1.2

6.51

4.10

u/ml

0.50

371

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.00

2.56

5.9

5.2

590.75

371.95

umol/l

—

(4146454) Self-monitoring of blood glucose

582

1.43

2.55

2.8

2.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.36

2.55

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

569

1.43

2.48

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

196

1572

1.26

2.45

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.46

2.44

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

513

1.45

2.43

3.7

3.4

11.62

13.30

index

1.08

296

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

268

0.41

2.42

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.29

2.41

1.3

1.2

44.00

53.52

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.17

2.40

1.9

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

590

1.41

2.39

1.7

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

278

2321

1.21

2.39

1.8

2.0

—

(3017704) Immunofixation for Urine

281

1.61

2.39

2.1

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.42

2.36

1.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

676

1.38

2.36

1.4

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

518

1.43

2.33

1.4

283.84

338.97

u/l

0.61

499

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

124

945

1.32

2.32

1.3

1.5

—

12.43

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.22

2.30

7.3

5.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

511

1.43

2.30

1.2

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4397

42965

1.09

2.29

29.1

21.1

331.26

332.11

g/l

7.75

4384

42747

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.12

2.28

1.9

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

554

1.41

2.27

3.7

3.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.69

2.20

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.80

2.19

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

686

1.36

2.18

1.1

—

(3035880) pH of Pleural fluid

296

1.56

2.18

1.3

1.4

7.39

7.40

0.09

198

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

165

1.76

2.18

1.7

1.6

9.70

8.90

ug/l

0.40

165

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

110

833

1.33

2.18

1.2

38.67

6.49

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

2.18

1.0

—

(3020650) Glucose [Presence] in Urine

188

1.71

2.16

2.1

1.8

0.22

0.02

estimate

0.70

188

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.29

2.15

1.5

1.1

26.80

34.44

mg/24h

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

101

1.98

2.15

1.8

2.0

19.38

17.49

umol/l

0.29

101

(3009466) Valproate [Moles/volume] in Serum or Plasma

743

1.34

2.09

5.7

5.4

351.41

356.93

umol/l

0.15

656

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

364

1.49

2.09

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

131

1.84

2.07

1.0

1.1

—

234.29

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

2.07

1.1

—

(4198724) Urine methamphetamine measurement

183

1.70

2.07

1.2

3.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

373

1.48

2.07

1.3

1.2

—

(40768443) Skin Pathology biopsy report

300

2567

1.18

2.01

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

255

1.57

2.00

1.6

1.5

1.17

3.49

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

263

1.56

2.00

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

368

1.47

1.99

1.3

1.2

—

(44806420) Estimation of glomerular filtration rate

595

1.37

1.98

2.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

232

1.60

1.98

3.2

2.1

34.73

30.47

1.00

232

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

128

1618

0.79

1.97

1.6

980.88

1009.86

mu/l

0.11

107

1332

(3003434) Protein [Mass/volume] in Pleural fluid

751

1.32

1.97

1.7

1.5

33.01

32.56

g/l

0.13

683

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.34

1.96

1.0

1.1

0.00

0.49

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.08

1.96

12.4

12.7

5.10

5.57

mmol/l

0.45

(21494434) Karyotype in Bone marrow

512

1.39

1.95

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.73

1.93

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

530

1.38

1.93

3.1

2.5

1224.33

1159.53

e6/l

0.24

469

(3036071) Salmonella sp Ab [Titer] in Serum

172

1.69

1.92

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

127

1003

1.27

1.88

1.4

141.10

152.95

au/ml

0.57

286

(37208534) Antinuclear antibody arbitrary concentration in serum

181

1.66

1.88

1.1

—

(3004775) Volume in Urine collected for unspecified duration

390

1.44

1.87

2.1

2.4

644.95

637.57

0.04

262

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

357

1.46

1.87

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

1.69

1.87

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

114

1.85

1.86

2.1

3.4

105.00

132.87

ng/l

0.21

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.65

1.86

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

100

1.90

1.85

2.1

2.0

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1.50

1.81

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

580

1.35

1.80

1.8

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

215

1.58

1.78

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

288

1.50

1.76

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

288

1.50

1.76

1.2

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

463

1.39

1.75

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

653

1.32

1.74

1.6

1.5

1310.48

3638.84

e6/l

0.98

452

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

464

1.38

1.73

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

209

1.58

1.73

1.9

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

732

1.30

1.73

1.3

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

155

1.68

1.72

4.2

3.7

49.81

53.26

0.29

148

(3003888) Timothy IgE Ab [Units/volume] in Serum

115

910

1.27

1.71

1.0

1.1

4.27

4.26

u/ml

0.00

473

(3023430) Cat dander IgE Ab [Units/volume] in Serum

690

1.31

1.70

1.0

1.1

2.32

4.02

u/ml

1.09

300

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

407

1.40

1.69

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

141

1.71

1.67

3.7

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

425

1.39

1.67

3.3

2.7

25.93

29.82

mg/l

0.33

311

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.66

1.6

6.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

3.16

1.66

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.16

1.66

1.2

—

(40768795) Lymph node Pathology biopsy report

580

1.33

1.65

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

746

1.29

1.65

1.0

1.1

2.29

3.30

u/ml

0.56

372

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

641

1.31

1.65

1.0

1.1

0.19

0.22

u/ml

0.06

217

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.03

1.64

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

607

1.32

1.64

10.7

15.4

7.75

7.22

mmol/l

0.40

509

(3004716) Salmonella sp identified in Stool by Organism specific culture

280

2429

1.16

1.63

1.2

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

302

1.46

1.62

1.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

352

1.42

1.62

1.4

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.57

1.61

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

185

1552

1.20

1.61

1.3

228.10

217.75

miu/ml

0.14

706

(3032868) Hemoglobin electrophoresis panel in Blood

2.15

1.61

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

230

1.52

1.59

3.1

3.4

1.69

1.28

0.30

230

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.33

1.58

2.8

2.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

299

1.44

1.50

1.1

1.2

—

(4015189) Microbial culture of sputum

123

1.71

1.50

2.4

2.3

—

(4281824) Cell count and differential, peritoneal fluid

634

1.30

1.50

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

409

1.37

1.49

1.0

830.16

724.46

ng/l

0.79

278

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

461

1.35

1.48

1.3

1.6

—

(3020491) Glucose [Moles/volume] in Blood

376

1.39

1.47

1.8

1.9

6.39

6.58

mmol/l

0.35

259

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

385

1.38

1.46

1.6

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.22

1.46

1.0

1.1

—

3.79

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1654

0.82

1.46

1.5

—

(3028433) Virus identified in Specimen by Culture

171

1.58

1.45

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

335

1.41

1.45

1.4

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

117

1.71

1.44

2.4

2.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

412

1.36

1.44

1.0

29.95

42.28

ng/l

2.58

283

(21494890) Protein electrophoresis panel - 24 hour Urine

568

1.31

1.43

2.4

2.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

551

5038

1.10

1.41

1.4

—

(3006270) Folate [Moles/volume] in Blood

431

1.35

1.40

1.2

1.1

340.92

366.04

nmol/l

0.39

376

(3045788) Cell count panel - Pleural fluid

544

1.31

1.40

1.6

1.5

—

(3034426) Prothrombin time (PT)

181

1.55

1.39

1.5

1.2

27.86

28.51

0.29

181

(3024891) Influenza virus A+B Ag [Presence] in Specimen

159

1337

1.19

1.39

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.75

1.34

1.0

1.4

—

(3016228) CD19 cells/cells in Blood

232

1.47

1.33

3.1

2.1

4.62

7.99

2.19

223

(3042517) Benzodiazepines panel - Urine

2.13

1.33

2.2

2.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

410

1.34

1.32

1.0

243.05

323.01

ng/l

2.65

286

(1761868) Lipid panel - Serum or Plasma

2106

20302

1.06

1.31

3.5

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

124

1026

1.21

1.30

3.5

3.3

0.83

0.81

nmol/l

0.16

100

819

(3008401) Mugwort IgE Ab [Units/volume] in Serum

108

882

1.23

1.29

1.0

1.1

1.43

1.01

u/ml

0.22

377

(3010726) Horse dander IgE Ab [Units/volume] in Serum

104

846

1.23

1.29

1.0

1.1

0.69

1.34

u/ml

1.88

426

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.78

1.28

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

319

1.38

1.26

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

311

1.39

1.25

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

130

1087

1.20

1.24

4.0

3.5

28.79

27.86

mg/l

0.12

743

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.22

1.24

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

512

1.29

1.22

1.5

1.4

136684.07

84112.16

e6/l

0.23

340

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.91

1.22

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

373

1.34

1.22

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

875

0.79

1.20

1.5

1.14

ratio

0.00

515

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

1.53

1.20

3.3

3.8

5.13

4.87

kpa

0.47

164

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

1.53

1.20

3.3

3.8

10.31

10.15

kpa

0.10

164

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

230

1.44

1.19

1.1

103.50

94.07

0.67

179

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.31

1.18

1.8

1.3

917.70

471.85

nmol/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

247

1.42

1.18

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

247

1.42

1.18

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

705

6577

1.08

1.18

5.3

5.0

31.83

32.39

0.67

509

4357

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

248

1.41

1.16

2.3

2.0

24.67

236.57

ug/min

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

207

1.45

1.14

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

207

1.45

1.14

1.9

2.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

232

1.42

1.14

1.9

1.7

41.23

39.97

g/l

0.80

232

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

317

1.36

1.14

1.1

1.11

1.06

ratio

0.81

255

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

266

1.39

1.14

1.4

—

1248823.00

—

(3002619) Bacteria identified in Specimen by Culture

134

1.57

1.14

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

715

1.23

1.14

1.1

5.79

3.27

eliau/ml

0.48

309

(3028308) Erythrocytes [#/volume] in Pleural fluid

581

1.26

1.13

1.6

1.4

41825.05

70870.10

e6/l

0.62

317

(3019832) Treponema pallidum Ab [Presence] in Serum

453

4156

1.10

1.13

1.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

466

1.29

1.12

1.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

208

1.44

1.12

1.9

2.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.33

1.12

10.4

9.3

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

119

1.60

1.11

1.6

1.4

22.57

23.87

0.06

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

875

0.80

1.10

1.5

1.12

1.17

ratio

0.17

518

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

875

0.80

1.10

1.5

0.91

0.95

ratio

0.50

515

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

251

1.40

1.10

1.3

1.7

1.37

3.46

u/field

1.35

176

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.38

1.09

14.0

10.0

103.20

106.38

g/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

160

1.50

1.09

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

160

1.50

1.09

1.3

1.2

36.51

39.17

g/l

0.38

(3014891) Appearance of Pleural fluid

1.82

1.08

2.1

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.73

1.08

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

193

1.45

1.08

1.6

1.5

65.91

64.11

0.10

157

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

144

1.53

1.08

1.6

1.3

38.81

33.42

0.25

(3036782) Glucose [Moles/volume] in Pleural fluid

549

1.26

1.08

1.4

6.26

6.31

mmol/l

0.06

517

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

127

1078

1.18

1.06

1.1

0.80

2.22

u/ml

3.49

576

(3020191) Ethanol [Moles/volume] in Serum or Plasma

453

1.28

1.06

1.1

1.5

1.06

1.17

promille

0.23

362

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

186

1.45

1.05

3.3

2.0

1.18

1.83

ratio

3.04

177

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

212

1.42

1.03

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.27

1.03

1.0

1.1

—

26.88

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

178

0.56

1.03

3.2

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

130

1.54

1.02

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.92

1.02

1.2

6.18

6.03

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

864

0.81

1.01

1.5

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

645

1.23

1.00

1.3

7.68

7.34

mmol/l

0.48

570

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.00

1.00

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

107

1.59

0.99

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

431

1.28

0.99

1.2

1.3

0.42

1.31

u/ml

1.52

250

(3013166) Neutrophils/Leukocytes in Synovial fluid

164

1.47

0.99

1.5

1.3

38.37

52.24

0.79

140

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

212

0.61

0.97

1.2

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

363

1.30

0.95

3.0

2.8

238.47

215.92

e6/l

0.29

312

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.95

0.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

479

1.26

0.94

3.5

3.1

170.34

38.10

mg/l

0.84

354

(3012441) Differential panel - Pleural fluid

569

1.23

0.94

1.7

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.65

0.94

4.2

7.0

8.00

8.13

mmol/l

0.08

(3033099) Centromere Ab [Titer] in Serum

125

1.52

0.93

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

400

1.28

0.93

2.4

1.9

1.13

1.57

u/field

0.54

209

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

356

1.29

0.92

2.7

642.29

507.59

e6/l

0.51

289

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

365

1.29

0.92

1.3

1.4

—

(3022621) pH of Urine by Test strip

472

4386

1.08

0.92

2.9

2.7

6.02

6.07

0.55

310

2970

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.07

0.89

2.8

3.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

228

1.36

0.88

1.1

189.75

187.97

iu/ml

0.01

228

(3016750) Collection duration of Urine

289

1.32

0.87

2.1

2.4

521.57

494.33

min

0.89

217

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

557

1.22

0.87

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

901

0.83

0.86

1.5

1.6

—

(3019150) Specific gravity of Urine by Refractometry

1313

12634

1.05

0.86

4.4

4.2

1.02

1.14

kg/l

0.50

929

8465

(3044009) aPTT.lupus sensitive (LA screen)

1.82

0.85

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.82

0.85

3.1

2.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

1.50

0.85

8.0

7.5

5.07

5.49

kpa

0.85

120

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.85

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

112

1.52

0.84

1.1

1.0

33.72

34.77

iu/ml

0.04

112

(3046861) Legionella sp Ag [Presence] in Urine

1.94

0.84

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

102

874

1.17

0.82

1.5

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

731

0.82

0.81

1.5

—

(3019174) dRVVT (LA screen)

1.70

0.80

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

729

1.18

0.79

1.4

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.82

0.79

1.0

2.23

4.71

u/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.67

0.78

1.1

—

338.30

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1074

0.85

0.78

1.5

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

758

1.18

0.78

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.56

0.78

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

148

1.42

0.77

1.7

1.5

21.04

22.92

0.12

136

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

941

0.85

0.75

1.5

61.58

59.69

ug/l

0.13

774

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

209

1.34

0.75

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

209

1.34

0.75

2.4

2.8

0.63

0.61

mmol/l

0.64

209

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

777

0.83

0.74

1.5

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.64

0.73

1.1

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

1.52

0.72

1.5

2.6

16.38

14.84

ml/dl

1.26

(3052592) Norovirus Ag [Presence] in Stool

1.55

0.71

1.1

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.62

0.71

1.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.92

0.70

1.0

1.1

9.59

8.44

mmol/l

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

—

0.17

—

(3035933) Granulocytes/Leukocytes in Blood

134

1189

1.13

0.70

3.1

3.4

59.10

58.09

0.40

134

1189

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.85

0.68

1.0

1.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.56

0.68

3.9

3.2

140.96

27.70

mg/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

748

0.84

0.68

1.7

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.68

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

584

1.18

0.68

2.4

28.93

30.45

iu/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

231

1.30

0.67

1.3

2.9

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.63

0.66

1.6

1.2

66.43

1863.62

u/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

0.00

0.16

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.65

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

269

1.27

0.63

1.1

1187.76

1489.48

miu/ml

0.84

269

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

181

1.33

0.63

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

225

1.29

0.63

1.0

1.1

3.84

5.20

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

717

0.85

0.61

1.5

1.18

1.28

1.30

503

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

576

0.83

0.60

1.4

1.5

61.61

60.60

ug/l

0.06

576

(3001893) Eosinophils/Leukocytes in Pleural fluid

165

1.33

0.60

1.7

1.5

2.42

2.68

0.05

140

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

743

1.15

0.58

1.1

2.34

2.83

—

124

(3012494) Peanut IgE Ab [Units/volume] in Serum

132

1.36

0.57

1.0

1.1

0.18

1.56

u/ml

1.16

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.67

0.56

7.2

4.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.67

0.56

1.2

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.56

1.2

1.6

358.17

336.83

umol/24h

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

168

1.31

0.54

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.58

0.54

1.7

2.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

116

1.38

0.54

1.1

—

(40757373) Influenza virus identified in Isolate

1.42

0.54

1.3

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

536

1.16

0.51

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

118

1.36

0.50

2.9

2.5

2796.44

67.58

ug/l

0.46

118

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

234

1.24

0.49

2.0

2.3

58.64

52.50

umol/l

0.32

203

(3001686) Cold agglutinin [Titer] in Serum or Plasma

110

1.36

0.48

1.2

1.3

—

103.00

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.40

0.48

5.8

7.1

10.78

10.50

0.21

(3028717) Thiamine [Mass/volume] in Blood

1.45

0.48

1.4

1.3

56.00

66.17

ug/l

1.23

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.45

0.48

1.1

2.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

235

1.24

0.48

4.1

4.8

6196.96

64.89

mg/l

0.48

174

(4133840) Spirometry

127

0.71

0.43

1.4

1.2

—

(3042733) HLA Ab [Presence] in Serum

175

1.26

0.43

5.5

4.8

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.41

0.43

1.5

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.56

0.42

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

360

1.17

0.41

1.2

1.4

94.00

64.17

titre

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.41

1.2

2.4

2.36

2.71

mg/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.3

—

314.53

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.41

0.0

1.2

—

215.27

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.41

0.0

1.9

—

(4094501) Cardiovascular stress test using bicycle ergometer

168

1563

1.08

0.41

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.10

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.36

0.41

1.0

1.1

0.02

0.03

u/ml

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.36

0.41

11.4

10.7

0.19

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.5

—

48.18

—

(3013762) Body weight Measured

0.00

0.40

0.0

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.39

0.40

1.0

1.1

0.01

6.30

u/ml

0.50

(3010375) cycloSPORINE [Mass/volume] in Blood

259

1.20

0.40

28.4

28.5

96.40

112.15

ug/l

1.09

213

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

427

1.15

0.39

1.2

1.6

21.40

20.91

u/ml

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.41

0.39

1.1

1.0

—

(4034850) Laboratory test

176

1646

1.07

0.38

9.3

10.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

894

1.10

0.38

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

133

1.28

0.38

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

151

1.26

0.38

1.1

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

430

0.86

0.37

1.3

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

—

26.00

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

—

28.59

—

(3047189) Immunofixation for 24 hour Urine

273

1.17

0.35

2.2

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.36

0.34

1.8

2.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

358

1.15

0.34

1.0

1.1

12.35

18.05

u/ml

0.95

150

(3017509) Phencyclidine [Presence] in Urine

1.33

0.33

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

625

1.11

0.33

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

895

1.09

0.32

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

1.27

0.31

1.1

1.2

—

(4212803) Bone marrow aspirate examination

1.32

0.30

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

296

1.15

0.30

1.0

0.24

2.45

u/ml

1.12

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.27

0.30

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

534

1.11

0.29

2.1

2.0

11.55

7.49

umol/l

0.59

381

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

900

1.08

0.29

1.1

21.72

16.15

au/ml

0.21

212

(3041806) Other cells [#/volume] in Blood by Manual count

106

0.75

0.29

1.0

1.6

0.51

0.48

e9/l

—

106

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

680

0.91

0.28

1.6

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

289

1.14

0.28

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.25

0.27

1.6

2.3

—

(40768793) Breast Pathology biopsy report

135

1429

0.94

0.26

1.4

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.68

0.26

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

160

0.81

0.26

1.8

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.67

0.25

4.4

3.2

23.20

43.72

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.67

0.25

8.8

6.5

8.20

8.55

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.22

0.25

1.1

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

822

8386

0.98

0.25

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

255

1.14

0.24

2.0

1.6

31.34

29.38

umol/l

0.42

239

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

218

1.15

0.23

1.5

1.7

4.12

483.29

pmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

1.28

0.23

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

333

1.11

0.22

1.4

127.25

190.36

pmol/l

1.11

333

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.36

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

201

1.14

0.21

2.6

2.4

111.28

149.62

nmol/l

1.22

175

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.25

0.20

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

164

1.16

0.20

1.0

10.97

11.70

u/ml

—

115

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.3

—

(3001729) Color of Synovial fluid

1.25

0.20

1.5

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.20

0.19

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

231

1.13

0.19

1.3

1.2

10.46

10.02

mm/h

0.06

231

(3050794) Legionella sp Ab [Presence] in Serum

1.15

0.19

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

175

1.14

0.18

1.3

1.4

84.42

126.40

nmol/l

1.37

128

(3038177) Helicobacter pylori Ab [Presence] in Serum

872

1.06

0.18

1.3

1.2

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

639

1.06

0.17

3.3

2.9

13.44

13.20

1.28

631

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

110

1.18

0.17

1.1

1.3

0.51

95.57

mg/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.75

0.17

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.74

0.17

1.0

1.1

10.56

8.09

u/ml

—

(3024932) HLA-DR beta [Type]

167

1.14

0.16

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

1.14

0.16

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

283

1.10

0.15

1.0

0.20

1.47

u/ml

—

(3024263) Appearance of Synovial fluid

293

1.09

0.15

1.5

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.08

0.14

3.8

6.0

—

2070.67

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

619

6283

0.98

0.14

8.1

6.7

—

(3024471) HLA-A [Type]

170

1.12

0.13

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

210

1.10

0.12

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

133

1.13

0.12

1.5

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

1.14

0.11

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

191

1.10

0.11

2.2

1.8

14311.33

18375.68

e6/l

—

(44813793) Dust mix specific IgE antibody measurement

366

1.07

0.11

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

184

1886

0.97

0.11

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

260

1.08

0.10

1.0

0.24

1.47

u/ml

—

(3013637) Mi-2 Ab [Presence] in Serum

167

0.90

0.10

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

167

0.90

0.10

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

167

0.90

0.10

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

167

0.90

0.10

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.11

0.09

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

254

2581

0.98

0.08

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

172

1686

1.02

0.08

1.6

1.8

—

32.21

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.78

0.08

1.2

1.8

1.38

1.36

umol/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.82

0.07

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.82

0.07

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.82

0.07

1.4

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

118

1.10

0.07

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.05

0.07

1.0

1.1

0.24

4.32

u/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

102

0.88

0.06

1.6

—

(3025577) Chromium [Mass/volume] in Blood

332

0.96

0.04

1.9

2.3

1.30

2.55

ug/l

2.92

280

(3026470) Cobalt [Mass/volume] in Blood

342

0.96

0.04

2.0

2.2

2.56

3.50

ug/l

0.73

317

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

398

1.03

0.04

1.1

8.91

8.66

iu/ml

0.03

114

(3037692) Legionella sp identified in Specimen by Organism specific culture

201

1.04

0.03

1.1

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

122

1.07

0.02

1.1

—

17.33

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

122

1.07

0.02

2.2

1.9

3.47

1.97

ug/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

168

0.95

0.02

1.4

18.02

13.09

g/l

1.20

124

(3044007) Cell count panel - Peritoneal fluid

197

0.96

0.01

2.4

1.9

—

(4211845) Urine protein measurement

267

0.97

0.01

5.3

3.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

277

0.97

0.01

6.9

6.1

31.29

126.29

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

189

1883

1.00

0.00

1.5

1.7

6.19

4.32

mg/l

0.80

149

1406

(3023487) Leukocytes [#/volume] in Peritoneal fluid

224

1.03

0.00

2.4

2.1

6514.38

4208.09

e6/l

0.13

157

(3006462) Nitrate [Presence] in Urine

244

1.02

0.00

5.5

3.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

434

1.01

0.00

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

178

1.01

0.00

1.3

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

175

1.03

0.00

3.5

14.64

8.30

mg/l

0.56

138

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

154

0.97

0.00

3.3

2.8

—

108.77

—

(40765096) Chromosome analysis panel by Banding

187

1.02

0.00

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

317

1.01

0.00

2.5

2.6

43.17

41.75

0.20

171

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.91

0.00

2.5

3.8

27.33

41.92

umol/l

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

2590.56

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.02

0.00

1.2

1.1

24.20

14.63

u/l

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

-0.00

0.0

8.6

—

6.46

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.93

-0.00

1.9

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

300

1.00

-0.00

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.88

-0.00

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.89

-0.00

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.97

-0.00

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

370

1.00

-0.00

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.2

—

5.83

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.87

-0.00

2.8

1.5

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.35

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_ENDOCRINE_OTH and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_ENDOCRINE_OTH	1.509 [1.35, 1.69]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.134

During the follow-up period (1.1.1998 — 31.12.2019), 1632 out of 11377 females with CD2_BENIGN_ENDOCRINE_OTH died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_ENDOCRINE_OTH	1.447 [1.28, 1.63]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1537 out of 7702 males with CD2_BENIGN_ENDOCRINE_OTH died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_ENDOCRINE_OTH.

N-year risk	Females	Males
1	0.12%	0.273%
5	0.818%	1.473%
10	2.041%	3.653%
15	4.03%	6.922%
20	6.935%	11.57%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ENDOCRINE_OTH – Benign neoplasm of other and unspecified endocrine glands

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm of other and unspecified endocrine glands

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints